Category: Nursing

Texas vs California APRN Board of Nursing Regulations Comparison Main Post 

Texas vs. California Comparison of APRN Board of Nursing Regulations

To safeguard the public, boards of nursing (BONs) regulate the nursing profession and make sure that nurses follow morally and safely. Each U.S. state and territory has a Board of Nursing Regulations (BON) that oversees the licensure of nurses, sets limitations on their scope of practice, and enforces adherence to local nursing regulations. Regulations pertaining to Advanced Practice Registered Nurses (APRNs) differ depending on the state. Prescriptive authority and scope of practice are the main topics of this discussion, which compares the APRN laws in Texas and California. These variations show how regulatory frameworks may impact patient care and nurse practice.

Texas and California’s Prescriptive Authority

In Texas, prior to an APRN can write a prescription, they must have a collaborative contract with a doctor. The law, also known as a prescriptive authority agreement (PAA), restricts APRNs’ autonomy to freely prescribe pharmaceuticals, including controlled substances, and calls for continual physician supervision (Texas Board of Nursing, 2021). Regular meetings with the supervising physician will be required by the agreement, which also specifies which medications the APRN may prescribe. Contrarily, California has made steps to improve the autonomy given to APRNs. Assembly Bill 890 was passed in California in 2020, and that follows a transition time. It allows APRNs to practice on their own, including writing prescriptions, without the need for physician supervision (California Board of Registered Nursing, 2020). As a result of this modification, APRNs in California now have more freedom than their counterparts in Texas to practice to the fullest extent of their education and training Texas vs California APRN Board of Nursing Regulations Comparison.

 GET YOUR ORDER NOW

Texas and California’s scope of practice

Between Texas and California, APRNs’ scopes of practice also vary greatly. In Texas, advanced practice registered nurses (APRNs) are bound by a practice agreement with a physician and other patient care necessities (Texas Board of Nursing, 2021). For instance, APRNs may find it difficult to handle patient care on their own if they must communicate with a doctor before making certain medical decisions. In contrast, APRNs in California are afforded greater autonomy. Qualified APRNs may practice independently of physicians in certain areas, which include outpatient services, family health, and primary care, under AB 890 (California Board of Registered Nursing, 2020). With the exception of underprivileged areas, this legislation permits APRNs in California to work with greater autonomy and provide care to a wider spectrum of patients.

Utilization for APRNs and Evidence of Compliance

APRNs who practice in states with differing regulatory frameworks are required to adjust to the new laws. To comply with prescriptive authority laws, for instance, an APRN in Texas might have to establish a close professional connection with a supervising physician. As part of the PAA, they would have to schedule regular conferences with the doctor and record their exchanges. In California, however, an APRN can receive the necessary transition time and be granted full autonomy to practice. They would not need direct medical supervision to prescribe drugs and administer patient care after they satisfied the state’s requirements.

For the safety and effectiveness of practice, advanced practice registered nurses (APRNs) in Texas and California are required to be aware of the legal requirements in their respective states. The trend of independent practice in California is a reflection of a larger national movement supporting greater autonomy for APRNs. Particularly in primary care and communities with limited resources, these differences in APRN regulation have an impact on the way care is provided Texas vs California APRN Board of Nursing Regulations Comparison.

In conclusion

The differences in state-by-state regulatory settings for nursing practice are illustrated by comparing the APRN laws of Texas and California. Physician supervision must be received for APRNs to prescribe medication and provide patient care in Texas due to certain restrictions. California, on the other hand, has given APRNs more freedom to work completely independently, which reflects how their role in the healthcare system has changed over time. For APRNs who practice across state lines or are thinking about getting multiple state licenses, it is necessary that they acknowledge these regulatory distinctions.

                                                                                      
References

California Board of Registered Nursing. (2020). 
Assembly Bill 890 – Nurse Practitioner scope of practice and regulation updates
. https://www.rn.ca.gov/pdfs/regulations/npr-b-62.pdf

Texas Board of Nursing. (2021). 
Prescriptive authority agreement FAQs
. https://www.bon.texas.gov/pdfs/law_rules_pdfs/rules_regulations

National Council of State Boards of Nursing (NCSBN). (2022). 
APRN Consensus Model: Overview and implementation status
. https://www.ncsbn.org/aprn-consensus.htm

National Academies of Sciences, Engineering, and Medicine (NASEM). (2021). 
The future of nursing 2020-2030: Charting a path to achieve health equity
. National Academies Press. https://doi.org/10.17226/25982 Texas vs California APRN Board of Nursing Regulations Comparison

NURS-6630 Week 1 discussion – Ion Channels and G Proteins

Ion Channels and G Proteins

This Discussion will allow you the opportunity to engage with your peers to explore the difference between ion channels and G proteins. You will be able to apply this understanding to a specific patient question. Additionally, please reply to your peers with additional information and sources to either support or challenge responses.

Resources

 

Be sure to review the Learning Resources before completing this activity.

Click the weekly resources link to access the resources.

WEEKLY RESOURCES

To prepare:

Review the Required Learning Resources.

Consider the difference between ion channels and G proteins.

By Day 3 of Week 1

Post
 a response answering the following:

Explain the difference between ion channels and G proteins as they relate to signal transduction and targets of medications.

How would you answer the following patient question:

My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?

Note: 
Your response needs to be supported and validated by three (3) scholarly peer-reviewed resources located 
outside
 of your course Learning Resources.

Upload a copy of your discussion writing to the draft Turnitin for plagiarism check.  Your faculty holds the academic freedom to not accept your work and grade at a zero if your work is not uploaded as a draft submission to Turnitin as instructed.

Read 
a selection of your colleagues’ posts.

By Day 6 of Week 1

You are required to participate in the Discussion on at least 3 different days (a different day for main post and each response). It is important to adhere to the weekly time frame to allow others ample time to respond to your posting.

Read 
a selection of your colleagues’ posts
.  Respond
 to 
at least two
 of your colleagues on 
2 different days
 by supporting or expanding on their explanation, as well as how they have described their response to the patient.

Peer responses should include at least two (2) supporting scholarly, peer-reviewed references 
outside
 of the provided Learning Resources. Your responses should also include additional resources to either support or refute the responses and should demonstrate critical thinking.

Note:
 Be sure you work to share additional perspectives on the details described by your colleague. Responses of “I agree” or “good point” will result in lower score grading.

NURS-6630 Week 1 discussion – Ion Channels and G Proteins

Main post
 

 
Cellular communication and function depend heavily on signal transduction, the process by which a cell reacts to outside stimuli. Ion channels and G proteins are two important participants in this process and important candidates for pharmaceutical treatments. These molecules differ greatly in their structure, function, and how drugs target them, even though they play similar functions in signal transduction.
 

Ion Channels: Overview and Purpose
 

Ion channels, which permit certain ions like sodium (Na⁺), potassium (K⁺), calcium (Ca²⁺), or chloride (Cl⁻) to flow through, are pore-forming proteins embedded in the cell membrane. These channels respond to various stimuli and can be voltage-gated, ligand-gated, or mechanically gated. Ion channels are essential for preserving the membrane potential at rest, producing action potentials, and controlling ion concentrations inside cells. For instance, potential action initiation and propagation in neurons depend on voltage-gated sodium channels. Ion channel-targeting medications frequently work by varying the opening or closure of the channels. One such would be local anesthetics such as lidocaine, which block voltage-gated sodium channels to stop nerve impulses from propagating and relieve pain (Hille, 2001).
 

G Proteins: Composition and Role
 

G proteins, sometimes referred to as guanine nucleotide-binding proteins, are molecular switches that transmit signals from intracellular signaling pathways to cell surface receptors called G protein-coupled receptors (GPCRs). When a ligand attaches itself to a GPCR, the receptor encourages the G protein’s alpha subunit to swap GDP for GTP, activating the corresponding G protein. G protein can affect several intracellular effectors like phospholipase C or adenylate cyclase, which can result in the production of second messengers like IP₃ or cAMP. G proteins are important targets for drug development because they are involved in many physiological processes. For example, beta-blockers, which are frequently used to treat hypertension, lower blood pressure and heart rate by blocking the function of G proteins connected to beta-adrenergic receptors (Rang, Dale, Ritter, & Flower, 2016).
 

BUY A PLAGIARISM-FREE PAPER HERE

G Proteins vs. Ion Channels for Drug Targeting
 

Ion channels and G proteins are equally essential for signal transduction, but the way that drugs target them is different. Drugs can directly target ion channels to either block or increase ion flow, which can modulate electrical activity or reactions within cells. Drugs that target G proteins, on the other hand, usually work on the receptors (GPCRs) that either activate these proteins or have an impact on the signaling cascades that they regulate downstream. The possibility to create medications that selectively target G protein signaling pathways while having no effect on other pathways mediated by the same receptor is one area of study in pharmacology. As evidenced by the creation of biased agonists, which specifically activate particular G protein pathways, this specificity may result in more potent therapies with fewer adverse effects (Wootten, Christopoulos, & Sexton, 2013).
 

G proteins and ion channels are both essential elements of signal transduction, although they function differently and are targeted differently by medications. Comprehending these variations is crucial for the advancement of more accurate and efficacious pharmaceutical interventions.
 

 
How would you answer the following patient question:
 

My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?
 

I would advise the patient that genetic predisposition can increase the risk of developing certain mental illnesses, but it does not guarantee that this patient will get the same mental illness. 
 

References
 

Hille, B. (2001). 
Ion channels of excitable membranes
 (3rd ed.). Sinauer Associates.
 

 
Rang, H. P., Dale, M. M., Ritter, J. M., & Flower, R. J. (2016). 
Rang and Dale’s Pharmacology
 (8th ed.). Elsevier.
 

 
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013). Emerging paradigms in GPCR allostery: implications for drug discovery. 
Nature Reviews Drug Discovery, 12
(8), 630-644. 
https://doi.org/10.1038/nrd4052
Links to an external site.
 

Expand discussion thread from Amanda Conley

6 Replies, 6 Unread

6 Replies, 6 Unread

Reply to post from Amanda Conley
Reply

Mark as Unread
Mark as Unread

DM

Destin Mcneill

Aug 30, 2024 12:36am
| 
Last reply Sep 1, 2024 9:53pm

Reply from Destin Mcneill

MAIN POST

Ion channels are proteins located in the cell membranes of all living organisms. Their job is to create pathways to allow specific ions like sodium, potassium, calcium, and chloride to pass through so physiological processes can take place in the living organisms it’s residing in. The ion channels open and close creating an immediate responses like cell excitability, muscle contractions, and neurotransmitter release. According to Cen et al., (2024) Lysosomes are highly dynamic organelles that maintain cellular homeostasis and regulate fundamental cellular processes by integrating multiple metabolic pathways. Lysosomal ion channels such as TRPML1-3, TPC1/2, ClC6/7, CLN7, and TMEM175 mediate the flux of Ca2+, Cl−, Na+ , H+ , and K+ across lysosomal membranes in response to osmotic stimulus, nutrient-dependent signals, and cellular stresses. These ion channels serve as the crucial transducers of cell signals and are essential for the regulation of lysosomal biogenesis, motility, membrane contact site formation, and lysosomal homeostasis. In terms of pathophysiology, genetic variations in these channel genes have been associated with the development of lysosomal storage diseases, neurodegenerative diseases, inflammation, and cancer. This review aims to discuss the current understanding of the role of these ion channels in the central nervous system and to assess their potential as drug targets. Some target medications of ion channels are calcium channel blockers, sodium channel blockers, and potassium channel openers.

G Proteins, or guanine nucleotide-binding proteins are molecular switches located intracellular that transmit signals outside the cell to inside the cell. They play a very essential role in intracellular signaling pathways, and are involved in many cellular processes like gene expression, cell growth, and metabolism changes. One of their main functions is their activation and inactivation cycle. Torres-Rodriguez (2024) Heterotrimeric G-proteins are universal signaling conduits in all eukaryotic groups, ranging from yeast and humans to algae and vascular plants. They regulate a variety of cellular processes involving millisecond-level responses, such as perception of light or neurotransmission in humans, to slower lifetime-level developmental aspects, such as body plan and architecture in plants. In all organisms, the core G-protein complex consists of one subunit each of the α, β, and γ proteins and exists in bimodal active 
versus
 inactive states. The transition between the active and inactive states is driven by the nucleotide-bound form of the Gα subunit. In the resting state, Gα is GDP-bound and associated with the Gβγ dimer. Signaling is initiated when the bound GDP is exchanged for GTP on Gα, which results in conformational changes that dissociate the heterotrimeric complex into Gα·GTP and Gβγ. Both entities can interact with downstream effectors to transduce the signal. Ion channels involve direct regulation signal transduction across the cell membrane. While G Proteins involve indirect signal transduction activation of signal pathways.

How I’d respond to the question would there is a possibility. But, not a definite yes or no. Because it depends on what the mental illness is, and what specific genes are involved, and/or inherited. Having the same genes as the grandma may increase the risk of developing a similar mental illness. But, it’s not a definite certainty. Mental illnesses are caused by multiple gene interactions. A Single gene that has no other genes to interact with will definitely not cause mental illnesses because it needs other genes to communicate with to even develop a mental illness.  Being the genes are not from the person’s immediate family, the parents, and from I guess a third party relative. Complex gene interactions, along with environmental and lifestyle factors influence mental illnesses. According to Hoy et al., (2023) In recent years, molecular genetic research has shifted its focus from candidate gene studies to genome-wide approaches in aiming to identify the genetic architecture underlying complex traits and disorders. For example, genome-wide association studies (GWASs) compare the frequencies of a large number (typically 500k-1 M) of common variants across the genome (e.g., single-nucleotide polymorphisms or SNPs) between cases of a given phenotype (e.g., depressed patients) and controls. Summary statistics from these studies can then be used to calculate polygenic scores (PGSs) in independent samples, providing a single quantitative metric of genetic risk for a particular trait or disorder based on the aggregate effects of genetic variants found to be associated with that phenotype through the relevant GWAS. These approaches capture polygenetic influences on psychiatric phenotypes (i.e., the contribution of multiple genetic variants to a given disorder) and have consistently demonstrated evidence of widespread pleiotropy across different forms of mental illness. That is, genetic variants influencing the expression of psychopathology are largely shared across putatively distinct diagnostic categories

Cen, J., Hu, N., Shen, J., Gao, Y., & Lu, H. (2024). Pathological Functions of Lysosomal Ion Channels in the Central Nervous System. 
International Journal of Molecular Sciences
, 
25
(12), 6565. https://doi.org/10.3390/ijms25126565

Hoy, N., Lynch, S. J., Waszczuk, M. A., Reppermund, S., & Mewton, L. (2023). Transdiagnostic biomarkers of mental illness across the lifespan: A systematic review examining the genetic and neural correlates of latent transdiagnostic dimensions of psychopathology in the general population. 
Neuroscience and Biobehavioral Reviews
, 
155
. https://doi.org/10.1016/j.neubiorev.2023.105431

Torres-Rodriguez, M. D., Lee, S. G., Roy Choudhury, S., Paul, R., Selvam, B., Shukla, D., Jez, J. M., & Pandey, S. (2024). Structure-function analysis of plant G-protein regulatory mechanisms identifies key Gα-RGS protein interactions. 
Journal of Biological Chemistry
, 
300
(5). https://doi.org/10.1016/j.jbc.2024.107252

Expand discussion thread from Destin Mcneill

5 Replies, 5 Unread

5 Replies, 5 Unread

Reply to post from Destin Mcneill
Reply

Mark as Unread
Mark as Unread

CS

Cheryl Athurine Spence

Aug 29, 2024 10:21pm
| 
Last reply Aug 31, 2024 8:16pm

Reply from Cheryl Athurine Spence

Response to post discussion 2

The Difference Between Ion Channels and G Proteins

Hello, Sharon. I liked your post on Ion channels and G protein. They are both essential aspects of cellular transduction, and although they react to different mechanisms, medications can target ions differently.  Ion channels are protein structures that form pores into cell membranes, enabling specific ions to go in or out. According to Raines et al. (2022), ion channels are relatively long macromolecules and made up of subunits extending the cell membrane. Ion channels are classified based on the ion that they allow to pass, such as sodium (Na
+
), potassium (K
+
), calcium (Ca
2+
), or chloride (Cl
−
) (Raines et al., 2022). Whenever they are active, they directly alter the cell’s electrical potential. Voltage changes, ligands, or mechanical forces trigger the channels. Medications that target ion channels tend to operate either through blocking or modulating their activity. According to Hutchings et al. (2019), ion channel proteins transport ions across cell membranes and play critical roles in various physiological and pathophysiological processes. Examples of medications targeting ion channels include local anesthetics, which block sodium channels, and benzodiazepines, which trigger the activity of GABA receptor chloride channels.

On the other hand, G proteins are intracellular signaling molecules that serve as molecular switches. These proteins are active when bound to GTP and inactive when the GTP becomes hydrolyzed to GDP. G proteins tend to be coupled with cell surface receptors called G protein-coupled receptors (GPCRs). In their study, Maggio et al. (2021) noted that G proteins are more characterized partners of GPCRs, are trimeric proteins that become activated when nucleotide GTP made up of α, β, and γ subunits with the α on one side and the β/γ subunits. When activated, G proteins activate cascades of intracellular events—the medications targeting the G protein work by activating or inhibiting GPCRs. An example of drugs targeting the G proteins are the beta-blockers that inhibit beta-adrenergic GPCRs and opioids that activate the opioid GPCRs.

The notable differences between ion channels and G proteins are based on their mechanisms and impacts. Ion channels directly impact cell excitability, with typically faster and shorter-term effects. On the other hand, G proteins initiate more complex signaling cascades that tend to have extensive and longer-lasting impacts. This simplifies the fact that medications targeting ion channels are likely to produce immediate effects. In contrast, those targeting proteins tend to have a more comprehensive, prolonged impact on cellular function.

Genetics and Mental Illness

To the patient having concerns about her mental health, given the family history, it is essential to understand the concerns as being genuine. With the grandmother having a mental illness, it increases the risk of mental health issues. Still, it is not a guarantee that the same mental condition will affect another family member. Mental health issues are complex and may be influenced by both genetic and environmental factors. According to Fabbri (2022), psychiatric disorders are complex diseases with genetic-environmental pathogenesis, where people are born with some level of genetic risk factors contributing to disease susceptibility while the environmental risk factors accumulate the susceptibility. When some threshold value has been reached, a person manifests an active episode of illness. While a family history of mental illness predisposes one to high susceptibility, whether the genes are expressed is also influenced by other factors such as life experiences, stress levels, and other environmental influences.

 

References

Fabbri, C. (2022). Genetics in psychiatry: Methods, clinical applications, and future perspectives. 
Psychiatry and Clinical Neurosciences Reports
, 
1
(2), e6. https://doi.org/10.1002/pcn5.6

Hutchings, C. J., Colussi, P., & Clark, T. G. (2019). Ion channels as therapeutic antibody targets. In 
MAbs
 (Vol. 11, No. 2, pp. 265-296). Taylor & Francis. https://doi.org/10.1080/19420862.2018.1548232

Maggio, R., Fasciani, I., Carli, M., Petragnano, F., Marampon, F., Rossi, M., & Scarselli, M. (2021). Integration and spatial organization of signaling by G protein-coupled receptor homo-and heterodimers. 
Biomolecules
, 
11
(12), 1828. https://doi.org/10.3390/biom11121828

Raines, R., McKnight, I., White, H., Legg, K., Lee, C., Li, W., … & Shim, J. W. (2022). Drug-targeted genomes: Mutability of ion channels and GPCRs. 
Biomedicines
, 
10
(3), 594. https://doi.org/10.3390/biomedicines10030594

Expand discussion thread from Cheryl Athurine Spence

2 Replies, 2 Unread

2 Replies, 2 Unread

Reply to post from Cheryl Athurine Spence
Reply

Mark as Unread
Mark as Unread

MM

Maria Kasmir Magbuo

Aug 29, 2024 7:31pm
| 
Last reply Sep 1, 2024 9:55pm

Reply from Maria Kasmir Magbuo

Hi Class

Functional and structural characteristics are two distinct areas in which ion channels and G proteins are significantly different from one another. Ion channels are proteins that produces gaps in cell membranes (Dai, 2023). These tiny openings allow certain ions such as potassium, sodium, chloride or calcium to move inside or out of the cell. Electrical signals are produced as a result of the movement of ions, and these electrical signals are essential for a variety of physiological activities, including the transmission of nerve impulses, the contraction of muscles (Dai, 2023), and the rhythm of the heart. When it comes to G proteins, this type of protein is found inside of cells that functions as molecular switches. They are related to receptors that are found on the surface of cells, which are known as G protein-coupled receptors or GPCRs (Fasciani et al., 2022). A ligand, which can be a hormone or a neurotransmitter, acts as the trigger for activating a receptor, which in response activates the G protein. The G protein eventually comes into contact with various different intracellular signaling molecules or pathways (Mafi et al., 2022).

Ion channels and G proteins individually have their own unique function in the process of signal transduction. It is possible for ion channels to be opened or closed directly in response to signals, such as neurotransmitters or medicines, which results in a rapid change in the membrane potential and activity of the cell (Dai, 2023). For instance, in response to neurotransmitters, neurotransmitter-gated ion channels open, allowing ions to travel through the membrane rapidly and influence cellular activity. In contrast, G proteins initiate more complex and slower signaling cascades. Rather than directly affecting the membrane potential, G proteins have the ability to either activate or inhibit a variety of enzymes and second messenger systems, such as calcium release or cAMP, which in turn leads to an extensive variety of cellular responses (Rehman et al., 2023). Compared to the quick and immediate effects of ion channels, this variation enables G protein channels to provide amplification and modulation of the initial signal, rendering them more adaptable and highly developed.

Drugs can selectively affect ion channels and G proteins based on their distinct mechanisms of therapeutic action. Drugs that target ion channels are developed with the intention of rapidly changing the flow of ions across cell membranes. For instance, pain signals can be blocked by local anesthetics by blocking sodium channels, while seizure activity can be reduced by anti-epileptic medications by stabilizing ion channels (Hernandez & Richards, 2023). G protein-coupled receptor (GPCR) or G protein targeted medications, on the other hand, influence cellular signaling pathways that are more complex. The action of GPCRs can be influenced by several medications, including beta-blockers, antihistamines, beta-blockers, and some psychiatric medications, which results in various therapeutic effects (Fasciani et al., 2022).  The differentiation demonstrates how drugs may selectively target ion channels to produce rapid effects or activate G protein pathways to achieve more complex regulatory effects.

When it comes to answering the patient’s question, my answer would be “There is some evidence suggesting mental disorders may have a hereditary component. Having a family history of mental illness is a risk factor, but it does not mean the individual will also have the disorder. There can be an intricate correlation of genetic, environmental, and lifestyle variables in the development of mental illness (National Institutes of Health, 2024). Even while you and your grandmother share similar biological traits, this does not necessarily guarantee that you will acquire the same disorder as her. Other aspects, such as the environment around you, the experiences you’ve had in life, and the amount of stress you’re under, all play a vital impact (National Institutes of Health, 2024). Establishing a discussion with a healthcare provider who can provide you with more individualized guidance and assistance is a great option if you have concerns regarding your mental health.

References

Dai, G. (2023). Signaling by Ion Channels: Pathways, Dynamics and Channelopathies. 
Missouri Medicine
. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569386/

Fasciani, I., Carli, M., Petragnano, F., Colaianni, F., Aloisi, G., Maggio, R., Scarselli, M., & Rossi, M. (2022). GPCRs in intracellular compartments: New targets for drug discovery. 
Biomolecules
, 
12
(10), 1343. https://doi.org/10.3390/biom12101343

Hernandez, C. M., & Richards, J. R. (2023). Physiology, Sodium Channels. 
StatPearls [Internet]
. https://www.ncbi.nlm.nih.gov/books/NBK545257/

Mafi, A., Kim, S., & Goddard, W. A. (2022). The mechanism for ligand activation of the GPCR–G protein complex. 
Proceedings of the National Academy of Sciences
, 
119
(18). https://doi.org/10.1073/pnas.2110085119

National Institutes of Health (NIH). (2024). 
Looking at my genes: What can they tell me about my mental health?
 National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/publications/looking-at-my-genes

Rehman, S., Rahimi, N., & Dimri, M. (2023). Biochemistry, G Protein Coupled Receptors. 
StatPearls [Internet]
. https://www.ncbi.nlm.nih.gov/books/NBK518966/

 

Expand discussion thread from Maria Kasmir Magbuo

4 Replies, 4 Unread

4 Replies, 4 Unread

Reply to post from Maria Kasmir Magbuo
Reply

Mark as Unread
Mark as Unread

KW

Kim White

Aug 28, 2024 10:39pm
| 
Last reply Sep 1, 2024 9:58pm

Reply from Kim White

Ion channels and G proteins play crucial roles in signal transduction, but they function differently and are targeted differently by medications. Ion channels are proteins that form pores in cell membranes, allowing specific ions (like sodium, potassium, or calcium) to pass through. This ion movement generates electrical signals, which are vital for processes like muscle contraction, neurotransmission, and heartbeat regulation. Medications that target ion channels often aim to modify these electrical signals. For instance, some antiepileptic drugs work by stabilizing ion channels to prevent abnormal electrical activity in the brain.

G proteins, on the other hand, are involved in a more complex signaling pathway. They act as molecular switches inside cells, transmitting signals from various receptors on the cell surface to internal cellular mechanisms. When a signaling molecule (like a hormone or neurotransmitter) binds to a receptor on the cell surface, it activates a G protein. This G protein then triggers various downstream effects, such as enzyme activity or gene expression changes. Many medications, including certain antipsychotics and antihypertensives, target G protein-coupled receptors (GPCRs) to modulate these pathways.

 

Regarding the patient asking the question about mental illness and genetics, it’s important to clarify that while genetics play a role in the risk for mental illness, having the same genes as a family member with a mental illness does not guarantee that you will develop the same condition. A combination of genetic, environmental, and lifestyle factors influences mental illnesses. For example, someone might inherit a genetic predisposition for a mental illness but never develop it because they do not encounter the same environmental triggers or stresses. It is also possible to take preventive steps, such as maintaining a healthy lifestyle and seeking early intervention if symptoms arise, to reduce the risk of developing mental illness. This can be a complicated but important thing to discuss with individuals as they worry about moving forward and having their own children.

 

References

 

American Psychiatric Association. (2020). 
The role of genetics in mental illness
. Retrieved from 
https://www.psychiatry.org
Links to an external site.

 

Kandel, E. R., Schwartz, J. H., & Jessell, T. M. (2021). 
Principles of neural science
 (6th ed.). McGraw-Hill Education.

 

Swanson, L. W. (2018). 
Brain architecture: Understanding the basic plan
 (2nd ed.). Oxford University Press.

G proteins and ion channels are both crucial components of signal transduction pathways, but they serve different roles and mechanisms in cellular communication and pharmacological targeting.

G Proteins

G proteins, or guanine nucleotide-binding proteins, act as molecular switches in signal transduction. They are typically associated with G protein-coupled receptors (GPCRs), which are membrane proteins that detect extracellular signals such as hormones and neurotransmitters (Ahmad & Dalziel, 2020). Upon ligand binding, GPCRs undergo a conformational change that activates the associated G protein, leading to the exchange of GDP for GTP on the alpha subunit of the G protein. This activation causes the G protein to dissociate into its active components: the alpha subunit (now bound to GTP) and the beta-gamma dimer. These components can then interact with various downstream effectors, such as enzymes that produce second messengers (e.g., cyclic AMP) or ion channels, thereby propagating the signal within the cell.

G proteins are significant targets for medications, as they regulate numerous physiological processes. Approximately 34% of all FDA-approved drugs target GPCRs, highlighting their importance in pharmacology (Liu et al., 2021). Drugs can either activate or inhibit GPCRs, leading to therapeutic effects in conditions such as hypertension, depression, and cancer.

Ion Channels

Ion channels, on the other hand, are integral membrane proteins that allow specific ions to flow across the cell membrane, thereby altering the membrane potential and facilitating rapid cellular responses. They can be ligand-gated or voltage-gated, with ligand-gated ion channels opening in response to the binding of a neurotransmitter or other signaling molecule (Alexander et al., 2023). This quick change in ion permeability is crucial for processes like neurotransmission and muscle contraction.

While ion channels can be directly targeted by drugs (e.g., calcium channel blockers for hypertension), they can also be indirectly influenced by G proteins. For instance, activated G proteins can modulate the activity of certain ion channels, enhancing or inhibiting their function as part of a broader signaling cascade. This interplay between G proteins and ion channels exemplifies the complexity of signal transduction pathways and highlights potential therapeutic targets for drug development.

How would you answer the following patient question:

My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?

While you and your grandmother may share the same genes, this does not mean you will necessarily develop the same mental illness. Mental health conditions are complex and result from a mix of genetic and environmental influences. Your unique experiences, lifestyle choices, and overall environment can greatly impact your mental health. It’s important to prioritize your well-being and consider factors beyond genetics that contribute to mental health. If you have concerns, discussing them with a healthcare professional can provide valuable insights and support.

References

Ahmad, R., & Dalziel, J. E. (2020). G protein-coupled receptors in taste physiology and pharmacology. 
Frontiers in pharmacology
, 
11
, 587664.

Alexander, S. P., Mathie, A. A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., … & Zhu, M. (2023). The concise guide to PHARMACOLOGY 2023/24: Ion channels. 
British Journal of Pharmacology
, 
180
, S145-S222.

Liu, N., Wang, Y., Li, T., & Feng, X. (2021). G-protein coupled receptors (GPCRs): signaling pathways, characterization, and functions in insect physiology and toxicology. 
International Journal of Molecular Sciences
, 
22
(10), 5260.

 

Expand discussion thread from Cheryl Suzannette Simpson

4 Replies, 4 Unread

4 Replies, 4 Unread

Reply to post from Cheryl Suzannette Simpson
Reply

Mark as Unread
Mark as Unread

AC

Alexis Carson

Aug 28, 2024 10:04pm
| 
Last reply Sep 1, 2024 11:56am

Reply from Alexis Carson

Week One Discussion Post Two

2) My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?

Genetics and mental illness are an interesting but complex topic. Although having a close family member with a mental illness could increase the chances of developing the same illness, it’s not likely that you will develop the same condition.

There are some factors to consider.

Genetic Factors

Heritability:
 Scientists have discovered evidence that many of the same genes have underlying distinct disorders, such as schizophrenia and autism, and changes in brain decision-making capacity could be involved in many of these illnesses. Genetic involvement in mental illness is seen through increased rates of disorders in first-degree family members who are diagnosed with disorders. Parents who are diagnosed with schizophrenia, bipolar disorders, and major depressive disorders, who have children, may have an increased risk of developing these illnesses but they may also develop other mental health disorders. Many factors contribute to the risk, but science has suggested that genetics carry the highest risk (Baselmans, et al, 2021).

Polygenic Nature: 
Mental illness is often influenced by many genes rather than just one gene, hence polygenic. There are
 
polygenic links seen in mental illnesses causing social behavior changes seen in adolescent development up to adulthood. Mental illness is polygenic but it’s unclear if mental illness is caused by genetics (Schlag, et al, 2022).

Gene-Environment Interaction and Life Experiences: 
Gene-by-environment interactions have shown that mental illness can be caused by environmental factors such as stress, trauma, lifestyle, and many other environmental factors. Combined with genetics and environmental factors, the interaction with genetic vulnerability is a risk of developing a psychiatric disorder even among individuals without a genetic predisposition. These can include drugs, and childhood trauma like being placed in a bad foster home, which can cause major polygenic depression, and even schizophrenia (Assary, et al, 2020).

Summary

Many risk factors can cause mental illness. You may have a higher risk of
developing a mental illness being
that your grandmother was diagnosed with a mental illness, it’s not guaranteed you will develop a disorder. As mentioned, environmental factors and genetics play a major part in the development of a psychiatric disorder. If you are worried about developing a mental illness, it is important to speak with your medical provider so they can help you maintain a healthy lifestyle and help you identify early signs and symptoms of mental illness, so you can manage any possible risks effectively.

 

Resources

Assary, E., Vincent, J., Machlitt-Northen, S., Keers, R., & Pluess, M. (2020). The role of gene-environment interaction in mental health and susceptibility to the development of psychiatric disorders. 
Beyond Our Genes: Pathophysiology of Gene and Environment Interaction and Epigenetic Inheritance
, 117-138.

Baselmans, B. M., Yengo, L., van Rheenen, W., & Wray, N. R. (2021). Risk in relatives, heritability, SNP-based heritability, and genetic correlations in psychiatric disorders: a review. 
Biological Psychiatry
, 
89
(1), 11-19.

Schlag, F., Allegrini, A. G., Buitelaar, J., Verhoef, E., van Donkelaar, M., Plomin, R., … & St Pourcain, B. (2022). Polygenic risk for mental disorder reveals distinct association profiles across social behaviour in the general population. 
Molecular psychiatry
, 
27
(3), 1588-1598.

Week One Discussion Post One

Explain the difference between ion channels and G proteins as they relate to signal transduction and targets of medications.

Ion channels and G proteins are two distinctive types of proteins that play an essential role in cellular signal transduction.

Ion channels produce fast signaling conduction proteins that assist the movement of ions like sodium, potassium, calcium, and chloride across the cell membrane. They can open and close in response to a signaling molecule like growth hormones, binding to it, which can change the flow across the membrane (Hille, 2022).

They are essential for generating electrical signals within cells and are involved in various physiological processes, including muscle contraction, nerve communication, and hormone production. Ion channels can be activated or respond rapidly to specific molecules such as neurotransmitters or hormones (Sakmann, 2022).

As drug targets, ion channels are frequently targeted by certain medications. For instance, drugs that block specific ion channels can be used as an anesthetic or antiepileptics, by interrupting or stopping the communication of electrical signals in the nervous system. Also, medications that modify ion channel movement can be used to regulate blood pressure and treat cardiac arrhythmias (Giffin, Khan, Basu, & Smith, 2020)

G proteins, like the ion channel, are also drug targets. G proteins are intracellular signaling proteins that connect cell surface receptors to target molecules within the cell. When a signaling molecule, such as a hormone or neurotransmitter, which are messengers that bring signals from outside the cells, binds to a cell surface receptor, it activates a specific G protein, G protein-coupled receptors (GPCR) (Yang et al., 2021).

Most body tissues contain G protein-coupled receptors. GPCRs are seen in many conditions such as diabetes, certain cancers, and cardiovascular diseases. By modifying signaling pathways, drugs can activate or stop specific G protein-coupled receptors (GPCRs). For example, Beta-Blockers work by preventing GPCRs from moving into cardiac cells, which causes the heart rate to decrease allowing the blood pressure to decrease (Davies & Tomas, 2023).

 

Resources

1) Davies, A., & Tomas, A. (2023). Appreciating the potential for GPCR crosstalk with ion channels. 
Progress in Molecular Biology and Translational Science
, 
195
, 101-120.

2) Griffin, M., Khan, R., Basu, S., & Smith, S. (2020). Ion channels as therapeutic targets in high grade gliomas. 
Cancers, 12
(10), 3068.

3) Hille, B. (2022). Ionic channels in nerve membranes, 50 years on. 
Progress in biophysics and molecular biology
, 
169
, 12-20.

4) Sakmann, B. (2022). Sparks in the Brain: The Story of Ion Channels and Nerve Cells. 
Front. Young Minds
, 
10
, 858193.

5) Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J. and Liu, Q., … & Wang, M. W. (2021). G protein-coupled receptors: structure-and function-based       drug discovery. 
Signal transduction and targeted therapy, 6(1), 7.

 

 

Expand discussion thread from Alexis Carson

1 Reply, 1 Unread

1 Reply, 1 Unread

Reply to post from Alexis Carson
Reply

Mark as Unread
Mark as Unread

NA

Negatu Engdaw Ahmed

Aug 28, 2024 10:02pm
| 
Last reply Sep 1, 2024 10:06pm

Reply from Negatu Engdaw Ahmed

NURS 6630 week I discussion.

The objective of this week’s discussion assignment is to discern the distinction between ion channels and G proteins in terms of their involvement in signal transduction and as targets of pharmaceuticals. As discussed below, ion channels and G proteins are essential elements in biological signaling networks, despite their distinct functions and drug targets.

Ion Channels

Ion channels are specialized membrane proteins that are responsible for creating holes or channels across the cell membrane. These channels enable certain ions to enter or leave the cell.

They are necessary for many physiological functions and serve an important role in maintaining cellular homeostasis and communication. In 2018, New Media gathered this data. There are approximately 400 ion channel genes in the human genome, which fall into three superfamilies: voltage-gated, ligand-gated, and mechano-sensitive.

Their function in signal transduction
:

Ion channels are important for almost all physiological processes, such as heartbeat control, muscle contraction, and neuronal transmission. Based on New Media 2018 information. Ion channels have a crucial role in nearly all physiological processes, including the regulation of heartbeat, muscular contraction, and neuronal transmission. Ion channels are protein structures that form pores in the cell membrane, facilitating the specific transport of particular ions (such as Na+, K+, Ca2+, or Cl-) across the cell membrane. When these channels become activated or deactivated, they modify the distribution of ions within the cell. This can quickly modify the cell’s membrane potential and have an impact on many physiological reactions, such as muscle contraction, release of neurotransmitters, and electrical communication in neurons. For example, the opening of sodium channels can lead to neuron depolarization, triggering an action potential. When these channels become activated or deactivated, they modify the distribution of ions within the cell, leading to a quick shift in the cell’s membrane potential (Martinac 2012).

The targets of medication

Medications frequently aim to modify the activity of ion channels. For example, the information from Cleveland Clinic (2022) explains the following medication targets.

i) Calcium channel blockers, such as verapamil and amlodipine, inhibit calcium entry into cardiac and smooth muscle cells to treat hypertension.

ii) Sodium channel blockers, like lidocaine, serve as both local anesthetics and antiarrhythmic medications.

iii) By delaying the repolarization process, potassium channel blockers like sotalol treat arrhythmias. (Cleveland Clinic, 2022)

B) 
G-proteins

A) Their function in signal transduction: 

The following information about G protein comes from Alberts, B. (1970).

G proteins are intracellular signaling molecules that transmit signals from receptors on the cell surface to different intracellular effectors. The binding of ligands to G proteins triggers the activation of related G proteins through the substitution of GTP for GDP. Upon activation, the alpha and beta subunits of the G protein separate and participate in signal transduction within the cell.

It directly influences ion channels or modulates enzymes such as adenylate cyclase and phospholipase C, which in turn govern several cellular functions (Alberts, B. (1970).

Targets of medications:

Medications that affect G protein-coupled receptors (GPCRs) have an indirect impact on G proteins, Sriram &  Insel (2018). For example:

i) Beta-blockers, such as propranolol, target beta-adrenergic receptors, which are G protein-coupled receptors (GPCRs). Doctors prescribe them to treat hypertension and heart problems.

ii) Opioids, such as morphine, exert their effects by binding to opioid receptors, which are a type of G protein-coupled receptors (GPCRs). This interaction influences the experience of pain and mood.

iii) Antihistamines, such as diphenhydramine, specifically act on histamine receptors, which are G protein-coupled receptors (GPCRs) that have a role in allergic reactions.

In conclusion, while both ion channels and G proteins are crucial for signal transduction, different classes of drugs target them and have unique mechanisms of action.

Regarding the lady’s inquiry, it should be noted that genetics plays a role in the likelihood of developing mental diseases; however, sharing the same genes as her grandmother does not guarantee that she will develop the same mental illness. However, mental health issues are not solely hereditary; lifestyle, environmental circumstances, and other variables can significantly influence the onset and progression of mental health issues (Würmann, 2021). It is also crucial to highlight that mental diseases are complicated and often caused by the interplay of numerous genes rather than a single gene. Because of this intricacy, even close relatives may have diverse mental health experiences. Supportive relationships, a healthy lifestyle, and stress management may all help to reduce the risk, even if there is a genetic propensity for differing mental health outcomes (Imbrici et al. (2016).

References:

Alberts, B. (1970, January 1). 
Signaling through G-protein-linked cell-surface receptors
. Molecular Biology of the Cell. 4th edition. https://www.ncbi.nlm.nih.gov/books/NBK26912/

Cleveland Clinic. (2022, January 7). 
Calcium Channel Blockers: Types, Uses and Side Effects
. Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/22316-calcium-channel-blockers

‌Imbrici, P., Liantonio, A., Camerino, G. M., De Bellis, M., Camerino, C., Mele, A., Giustino, A., Pierno, S., De Luca, A., Tricarico, D., Desaphy, J., & Conte, D. (2016). Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery. 
Frontiers in Pharmacology
, 
7
. 
https://doi.org/10.3389/fphar.2016.00121
Links to an external site.
    )

Martinac, B. (2012). Mechanosensitive ion channels. 
Channels
, 
6
(4), 211–213. https://doi.org/10.4161/chan.22047

 

News-Medical. “Importance of Ion Channels in the Body.” News-Medical.net, 26 Oct. 2018, www.news-medical.net/health/Importance-of-Ion-Channels-in-the-Body.aspx.

Sriram, Krishna, and Paul A. Insel. “G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?” 
Molecular Pharmacology
, vol. 93, no. 4, 3 Jan. 2018, pp. 251–258, https://doi.org/10.1124/mol.117.111062.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590096/

Würmann, Isaac. “My Mother and I Have the Same Mental Health Disorders. But Is It Genetic? | Broadview Magazine.” Broadview Magazine, 5 Oct. 2021, broadview.org/mental-illness-family-genetics/. Accessed 29 Aug. 2024

NURSE 6630 week 1 discussion-2.docx

Expand discussion thread from Negatu Engdaw Ahmed

2 Replies, 2 Unread

2 Replies, 2 Unread

Reply to post from Negatu Engdaw Ahmed
Reply

Mark as Unread
Mark as Unread

CS

Cheryl Athurine Spence

Aug 28, 2024 9:40pm
| 
Last reply Sep 1, 2024 10:08pm

Reply from Cheryl Athurine Spence

The Difference between Ion Channels and G Proteins in Signal Transduction and Medication Targets

Ion channels and G proteins are cellular signaling pathways involved in various forms of cellular transduction. For instance, an ion channel is any inherent protein part of the cell membrane that enables the selective transport of ions essential in generating electrical signals in cells. Ion channels are selective for Na
+
, K
+
, Ca
2+
, or Cl
–
 (Duncan et al., 2020). These channels transport ions and play significant roles in physiological activities such as nerve impulse conduction, muscle contraction, and osmoregulation at the cellular level. Ion channels are categorized as voltage-dependent channels, which can open depending on the voltage variation of the cell membrane, and the ligand-dependent channel, which opens when in contact with certain substances (Langenhan, 2020).

For example, in neurons, when a neurotransmitter engages with its receptor, it can potentiate the ion channels to open, leading to the flow of sodium ions into the neuron, creating an action potential. This process is faster because of the direct nature of the ion channel current. It suits them when one requires a quick signal, such as muscle contraction and nerve impulses. Thus, the drugs that act on these channels can regulate cellular excitability, such as anti-arrhythmic medicines, which can interfere with ion channels and restore the regular heartbeat.

G proteins interact with several types of cell surface receptors collectively known as G protein-coupled receptors (GPCRs). After binding the ligand to a GPCR, the receptor causes the activation of the G protein through the replacement of GDP by GTP. Subsequently, the G proteins get activated, and they, in turn, get involved with other effectors like enzymes or ion channels to relay the signal (Langenhan, 2020). This mechanism makes the response longer and more diverse than the effect that occurs with the participation of ion channels. G proteins can regulate so many body activities and thereby affect several functions of the body (Duncan et al., 2020). Medications targeting G proteins or GPCRs can treat a variety of conditions, such as antipsychotic medications, to control the symptoms of patients dealing with mental disorders.

It is important to note that some mental disorders are inherited. Similar genes are associated with the family tree, such as the grandmother, which can imply the existence of a genetic tendency toward mental health conditions. However, the problem provides a narrow concept of thinking. For instance, there can be other causes of mental conditions, such as environmental factors and coping styles of an individual (Zhang et al., 2023).

With the genetic makeup and cultural differences, family members are prone to have the same similarities in developing the same disorders. However, there can be a thought that one may get a hint of what kind of disorder they are prone to by family history; this does not always mean one will develop the disorder. A person’s genes may make them more likely to have mental illness. Still, the environment and the individual’s psychological conditions will dictate whether the person gets the disease. It is essential to explain the necessity of people turning to more of healthier coping strategies, asking for help whenever desired from specialists, and learning how to identify symptoms of mental health before becoming diagnosed with a mental illness.

 

References

Duncan, A. L., Song, W., & Sansom, M. S. (2020). Lipid-dependent regulation of ion channels and G protein-coupled receptors: insights from structures and simulations. 
Annual review of pharmacology and toxicology
, 
60
(1), 31–50.

Langenhan, T. (2020). Adhesion G protein-coupled receptors—Candidate metabotropic mechanosensory and novel drug targets. 
Basic & clinical pharmacology & toxicology
, 
126
, 5–16.

Zhang, M., Ma, Y., Ye, X., Zhang, N., Pan, L., & Wang, B. (2023). TRP (transient receptor potential) ion channel family: Structures, biological functions and therapeutic interventions for diseases. 
Signal Transduction and Targeted Therapy
, 
8
(1), 261.

Expand discussion thread from Cheryl Athurine Spence

3 Replies, 3 Unread

3 Replies, 3 Unread

Reply to post from Cheryl Athurine Spence
Reply

Mark as Unread
Mark as Unread

ST

Sarah Rachael Tabor

Aug 28, 2024 9:18pm
| 
Last reply Sep 1, 2024 10:11pm

Reply from Sarah Rachael Tabor

Good afternoon class.  I’m so grateful to be here and look forward to learning alongside you all.  This first week was interesting for me because it’s been a while since I reviewed the specificity of the cell and the very minute and detailed things that have to occur for signals to be sent through neurons.  It was humbling to review this information and to remember all of the intricate processes that have to happen for our brains to function the way they do.

Signal transduction includes all molecular events that take place between the arrival of a signaling molecule of the target cell and the response.  Two pathways for this conduction to occur include the G-protein pathway and ion channel pathway.  (Chandler, 2022).  It’s all about signal transduction.  That’s where the magic happens.  Everything that we are able to do is through the adequate conduction of these signals.

The brain is approximated to have about 85 billion neurons!  Incredible.  Neurons are nerve cells which are the units that make up the nervous system.  Neurons are made up of structures that receive messages, process these messages, transport messages and then ultimately pass on the messages.  Dendrites are the portion of the neuron that receives signals from other neurons called neurotransmitters.  Chemical changes that occur secondary to the reception of the neurotransmitters are processed in the Soma or the cell body.  The Soma contains the nucleus and genetic material of the cell.  The interpreted message is then sent to the Axon Hillock of the neuron, then it is sent to the Axon where it is now called the action potential.  This portion of the neuron is enclosed in Myelin which is a protective characteristic which prevents the action potential from degrading.  When the signal reaches the axon terminals there is potential for the signal to be sent to the next neuron if it was strong enough. (Nei psychopharm, 2022).  That is, for the message to continue to pass through the cells of the nervous system.

G-proteins and ion channels are structures within the cell that are pathways or neurotransmitter receptors for ions to be passed through.  (Alberts, Johnson, Lewis, et al., 2002).  The messages that are sent through these potential pathways may be potentiated by things such as medications and hormones.  (Neuroscientifically Challenged, July 2014).

For Ion channels, the neurotransmitters attach to the binding site causing it to open and then ions are able to send the action signal through the neuron.  The neurotransmitter that attaches to the binding site is called the Ligand.  After the Ligand is attached to the binding site the channel immediately opens.  (Neuroscientifically Challenged, September 2014).

G-proteins have an activation neurotransmitter that must be received to activate the G protein to influence opening the channel for pathways.  This G protein has the capability of opening more than it’s single pathway.  This pathway also impacts other activity in the cell.  These receptors act slower but may have a more widespread impact because of the potential influence on other activities in the cell.  Both of these pathways are located at the site of the receptor neuron or the dendrite where signals are received.

There are some mental illnesses that have been thought of as “running in families” but little evidence has been found to ascertain whether there are definitive genetic determinants.  Autism as an example is associated with signs such as early and rapid brain growth in infancy and childhood associated with atypical connectivity between different regions of the brain.  Research suggests a strong genetic influence but environmental factors also have significant influence on this condition as well.  (Neuroscientifically Challenged, 2021).  When discussing genetics and the concern for being diagnosed with a mental illness based off of what happened with a person’s grandma one would have to look at the specific condition and take environmental factors into consideration as well.

So ultimately my response to this woman would be not to worry too much about developing her grandmother’s condition.  I would discuss with her things to look for if she is deeply concerned but as long as she was not dealing with any of the particular symptoms of the particular condition, just encourage her to focus on the positive things in her life.

Sources

Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Ion Channels and the Electrical Properties of Membranes. Available from: https://www.ncbi.nlm.nih.gov/books/NBK26910/

Chandler, R., PhD. (2022). Signal transduction. 
Salem Press Encyclopedia of Health
.

NEI Psychopharm. (2022, March 14).
Classic synaptic neurotransmission
Links to an external site.

Links to an external site.
Links to an external site.

[Video]. YouTube.

Links to an external site.

Neuroscientifically Challenged. (2014, July 22).
2-Minute neuroscience: Synaptic transmission
Links to an external site.

Links to an external site.
Links to an external site.

[Video]. YouTube. 

Links to an external site.

Neuroscientifically Challenged. (2014, Sept 26).
2-Minute neuroscience: Receptors & ligands 
Links to an external site.
Links to an external site.
[Video]. YouTube. https://www.youtube.com/watch?v=NXOXZ-kaSVI

 

Neuroscientifically Challenged.  (2021, Dec. 20).  
2-Minute Neuroscience: Autism
. 
2-Minute Neuroscience: Autism (youtube.com)
Links to an external site.
  Accessed Aug. 28, 2024.

Expand discussion thread from Sarah Rachael Tabor

1 Reply, 1 Unread

1 Reply, 1 Unread

Reply to post from Sarah Rachael Tabor
Reply

Mark as Unread
Mark as Unread

AF

Abosede Fakorede

Aug 28, 2024 8:07pm
| 
Last reply Sep 1, 2024 10:13pm

Reply from Abosede Fakorede

The difference between ion channels and G proteins as they relate to signal transduction and targets of medications

Ion channels and G proteins are proteins involved in signal transduction in cells thus associated with the mode of action and therapeutic effect of many drugs. The two proteins are involved in the transmission of signals across cell membranes and response to the signals. Although ion channels and G proteins are transmembrane proteins involved in signal transduction, the two work in different manners to cause a certain response. Ion channels are transmembrane proteins that ensure signal transduction by forming pores through which ions pass in and out of cells (Alexander et al., 2023). Ion channels allow specific ions across the cell membrane through the formation of specific pores for the specific ions. Ion channels directly transmit specific ions through the direct opening and closing of gated ion channels. For example, sodium ions use sodium ion channels to cause action potential. The pores directly open or close when certain molecules bind to receptors in the cell membrane, when electoral potential across the cell membrane changes, or when physical stress causes the pores or channels to mechanically open. Signal transduction involving ion channels is direct unlike signal transduction involving G proteins which is complex. Some medications such as calcium blockers work by targeting ion channels by causing direct opening or closing of ion channels (Alexander et al., 2023). Calcium channel blockers prevent calcium ions from entering into cells thus reducing muscle relaxation and contraction.

The major difference between G proteins and ion channels is that G proteins involve a complex signal transduction system while ion channels involve a simple or direct signal transduction process. G proteins indirectly cause signal transduction (Jiang et al., 2022). Two steps are involved in signal transduction when G proteins are involved. Signals must first bind to G-protein-coupled receptors (GPCRs) to activate the G protein. The G protein then interacts, activates, or inhibits various proteins or targets including enzymes and ion channels to cause cellular response (Ahmad & Dalziel, 2020). Cellular response involving G proteins includes changes in the activities of enzymes and expression of genes. Some medications work by targeting or influencing GPCRs and G proteins in cell membranes to cause the intended therapeutic effects. Beta-blockers and most antipsychotics for depression target the G proteins and GPCRs. G proteins mainly involve ligands where signals bind to receptors to cause signal transduction (Ahmad & Dalziel, 2020). Specific indirect neurotransmitters such as adrenaline that act on specific receptors are influenced to cause cellular response.

My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?

Since my grandmother is my relative, we share the same gene. However, having the same genes does not mean I will get the same mental diseases as my grandmother. Genetic predisposition or family history increases the risk of developing genetic conditions but does not guarantee the direct development of the conditions. An interplay or interaction of genetic factors, environmental factors such as temperature, and lifestyle factors are required for the development of mental health illnesses. One may have a family history of mental disorders but may not develop the mental disorders.

References

Ahmad, R., & Dalziel, J. E. (2020). G protein-coupled receptors in taste physiology and pharmacology. 
Frontiers in pharmacology
, 
11
, 587664.

Alexander, S. P., Mathie, A. A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., … & Zhu, M. (2023). The concise guide to PHARMACOLOGY 2023/24: Ion channels. 
British Journal of Pharmacology
, 
180
, S145-S222.

Duncan, A. L., Song, W., & Sansom, M. S. (2020). Lipid-dependent regulation of ion channels and G protein–coupled receptors: insights from structures and simulations. 
Annual review of pharmacology and toxicology
, 
60
(1), 31-50.

Jiang, H., Galtes, D., Wang, J., & Rockman, H. A. (2022). G protein-coupled receptor signaling: transducers and effectors. 
American Journal of Physiology-Cell Physiology
, 
323
(3), C731-C748.

Expand discussion thread from Abosede Fakorede

3 Replies, 3 Unread

3 Replies, 3 Unread

Reply to post from Abosede Fakorede
Reply

Mark as Unread
Mark as Unread

AC

Ashli Cyriaano

Aug 28, 2024 6:34pm
| 
Last reply Sep 1, 2024 10:15pm

Reply from Ashli Cyriaano

Ion Channels and G Proteins

Ion channels and G proteins transmit signals in cells in different ways, determining how cells will respond to stimuli. Ion channels represent a class of proteins embedded in the cell membrane and create channels for certain ions. It is important for the shifting of the membrane potential in a very short time, which makes cellular responses to stimuli very fast (Bionet, 2021). For instance, voltage-gated sodium channels are integral components of neurons in transmitting action potentials. Ion channel-linked drugs, ranging from antiarrhythmic drugs to drugs used in the treatment of epilepsy, seek to block or modulate these channels to correct an electrochemical imbalance within the heart or nervous system.

On the other hand, G proteins are signal transducers that act as signaling molecules inside the cell that connect the GPCR at the cell membrane to intracellular effectors such as enzymes or ion channels. When a GPCR binds to its ligand, it promotes the exchange of GDP with GTP for the G protein to become activated. This activation then leads to the activation of other pathways or downstream signaling pathways (Rehman et al., 2023). Ion channels signal faster and transient responses, while G-proteins signal slower and sustained cellular responses. The G protein-directed drugs normally interact with the GPCR to alter physiological processes such as mood or blood pressure. For example, some of the drugs used in the treatment of depression work by interacting with GPCRs to alter concentrations of neurotransmitters and, thus, the feelings and moods of the patient.

Patient Question Response

In terms of family inheritance of mental disorders, yes, having a grandmother with such a disorder does put one at higher risk for similar disorders due to the general inheritance of certain genes. However, genetics alone cannot predict risks and is only one factor in various possibilities. Other causes of mental health disorders are framed within aspects of the environment, real-life decisions people make, and their life experiences as well. However, this does not mean that if one has inherited genes for a certain mental illness, then one is bound to develop that disorder (Andreassen et al., 2023). Research shows that even though certain genes make one vulnerable to developing certain mental health disorders, the overall vulnerability is a function of the genes and environment interface (Boyce et al., 2020). As a result, even though one has to be conscious of certain congenital abnormalities, one must also pay much attention to other factors of wellness and living with proper precautions to prevent possible mental health problems.

References

Andreassen, O. A., Hindley, G. F., Frei, O., & Smeland, O. B. (2023). New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. 
World Psychiatry
, 
22
(1), 4-24.

Bionet. (2021, March 8). 
Ion channels
 [Video]. YouTube.
https://www.youtube.com/watch?v=0p08-139
Links to an external site.

Boyce, W. T., Sokolowski, M. B., & Robinson, G. E. (2020). Genes and environments, development and time. 
Proceedings of the National Academy of Sciences of the United States of America
, 
117
(38), 23235–23241. 
https://doi.org/10.1073/pnas.2016710117
Links to an external site.

Rehman, S., Rahimi, N., & Dimri, M. (2023, July 30). 
Biochemistry, G protein coupled receptors
. StatPearls – NCBI Bookshelf. 
https://www.ncbi.nlm.nih.gov/books/NBK518966/
Links to an external site.

Expand discussion thread from Ashli Cyriaano

2 Replies, 2 Unread

2 Replies, 2 Unread

Reply to post from Ashli Cyriaano
Reply

Mark as Unread
Mark as Unread

TF

Tenikqua Fullwood-Maple

Aug 28, 2024 4:30pm
| 
Last reply Sep 1, 2024 10:19pm

Reply from Tenikqua Fullwood-Maple

 Initial Post

Signal transduction

There are four very important transduction cascades that are in the brain, out of the four I will be discussing two of them. (Stahl, 2021) indicated that there are four most important signal transduction cascades in the brain, g-protein-linked systems, ion-channel-linked systems, hormone-linked systems and neurotrophins-linked systems. The two that will be discussed in this discussion are G-protein-linked systems and ion-channel-linked system. Each of these transduction cascades are initiated by a first messenger, such as g-protein and ion-channel. There are chemical messengers that are attached to each of the signal transduction cascades and are triggered by neurotransmitters. Once there is an activation of the first messenger there is a trickle-down effect, that then activates second, third, and fourth messenger. The signal transduction cascades ultimately pass its message from an extracellular first messenger to intracellular second messenger. In reference to the g-protein, its second messenger is a chemical as cAMP. In reference to ion-channel, its second messenger can be an ion and that ion can be a calcium ion. In reference to the g-protein, the third messenger protein kinase is activated from Camp. In reference to the ion-channel, the third messenger phosphatase is activated through the messenger calcium.

G-Protein

Psychotropic medication has an array of actions, by which they target specific molecular areas that potentially have an extensive effect on neurotransmitters. Psychotropic drugs can target five molecular sites. Out of the five one is g-protein, thirty percent of psychotropic medications target the g-protein. Twenty percent of psychotropic medications target the ion channels. The superfamily of seven transmembrane receptors is characterized by having seven highly conserved transmembrane alpha helices (Seyedabadi, Ghahremani, Albert, 2019). With g-protein being one of the larger membrane protein family, which contains seven transmembrane, allowing the nervous system to respond appropriately to external and internal stimuli. The unique ligand binding pockets formed by the seven transmembrane receptors regions allow the receptor to engage with various stimuli, including neurotransmitters, nucleotides, amines, peptides, cytokines, and hormones in the extracellular environment (Wong, 
et al, 
2023). Psychotropic medications interact at the neurotransmitter binding site that is located on the receptor. When this interaction occurs, it leads to modification of the receptors actions, resulting in mimicking, blocking, partially or fully, the function of the neurotransmitter. When psychotropic medication interacts at the g-protein, it alters molecular events further downstream of the g-protein. At the level of the g-protein-linked receptor, the g-protein have a sufficient action on psychiatric symptoms. Most psychotropic medications that are used in the clinical setting have an action on the g-protein, which results in a therapeutic manner or causes some side effects.

Ion Channels

Ion channels regulate calcium, sodium, chloride, and potassium, in reference to psychotropic medications. There are a number of psychotropic medications that act at the site of ion channels, resulting in modifications of the ion channel. The modifications that occur can alter the flow of ions throughout the channel but can also alter the downstream events. These downstream events can result in activation or inactivation of ion channels. Psychotropic medications that modify signal transduction from ionotropic receptors can have a major impact on a person that is displaying psychiatric symptoms. Several psychotropic medications that are used in clinical settings such as benzodiazepines, are known to act as the ionotropic receptor sites. The flow of ions is immediately changed at the ionotropic receptor, medications tend to have an immediate effect action, by which the drugs that are used for anxiety and sleep may have a rapid onset.

My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?

Mental illness is a serious illness and sometimes can be scary for family members of those who suffer with mental illness. Your question of concern is a good question. Many things are passed on from one generation to the next, by our genetic, but fortunately not all illness or diseases are passed through genetics. Although mental illness has a genetic component, which in saying it can run throughout families, but having a family as your grandmother that suffers with mental illness doesn’t automatically guarantee that you will suffer with the same mental illness. Most genetic variants don’t directly cause mental disorders (National Institute of Mental Health, 2024). There are some genetic components that can increase the risk of mental illness but doesn’t directly cause one to develop the mental illness. When taking care of a family member or surrounding yourself with a family member with mental illness, it is important you also take care of your mental health, because it can be a stressful and mentally draining situation when dealing with someone who suffers with a mental illness. However, if the sick person received care that was professional, adequate and of a high standard, the relatives’ stress and burden decreased (Kallquist & Salzmann-Erikson, 2022). There are ways to increase a healthier mental health, by decreasing or alleviating stress factors, healthy habits, and having a great support system. It is also important that you seek help or assistance if you feel that you may be suffering with signs or symptoms related to mental help, the best way to address mental illness is addressing and treating signs and symptoms early on.

Reference

Goldin, D. S. (2023). 
Fast facts for psychopharmacology for nurse practitioners
. Springer

Publishing. Chapter 3, “The Brain and Nervous System” (pp. 28)

Kallquist, A. & Salzmann-Erikson, M. 2022. Journal of Child and Family studies. Springer

Publishing. 
Experiences of Having a Parent with Serious Mental Illness: An Interpretive Meta-Synthesis of Qualitative Literature | Journal of Child and Family Studies (springer.com)
Links to an external site.

Seyedabadi, M., Ghahremani, M., & Albert, P. Biased signaling of G protein coupled receptors

(GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential, Pharmacology & Therapeutics, Volume 200 ,2019, Pages 148-178, ISSN 0163-7258, 
https://doi.org/10.1016/j.pharmthera.2019.05.006
Links to an external site.
.

Wong, TS. 
et al.
 G protein-coupled receptors in neurodegenerative diseases and psychiatric

disorders. 
Sig Transduct Target Ther
 
8
, 177 (2023). 
https://doi.org/10.1038/s41392-023-
Links to an external site.
01427-2

 

 

Expand discussion thread from Tenikqua Fullwood-Maple

2 Replies, 2 Unread

2 Replies, 2 Unread

Reply to post from Tenikqua Fullwood-Maple
Reply

Mark as Unread
Mark as Unread

SH

Sharon Harrison

Aug 28, 2024 3:01pm
| 
Last reply Sep 1, 2024 10:20pm

Reply from Sharon Harrison

Week 1 Discussion

Ion channels and G proteins both play different roles in signal transduction within cells. Ion channels are membrane proteins that allow ions to move across cell membranes (Cen et al., 2024). Sodium, potassium, calcium, and chloride are some examples of ions that can pass through ion channels. In addition to being involved in various psychological processes such as muscle contraction, nerve impulse transmission, and hormone release, they are required to generate electrical signals within cells. Ion channels are typically activated by voltage changes or the binding of specific molecules, such as neurotransmitters or hormones. Because medications commonly target ion channels, they are considered drug targets. For example, medications that block specific ion channels can be used as anesthetics or antiepileptics to prevent electrical signals from transmitting throughout the nervous system. Similarly, medications that modulate ion channel activity can be used to treat cardiac arrhythmias and regulate blood pressure.

G proteins are intracellular signaling proteins that send signals from receptors on the cell’s surface to target molecules inside the cell. When a signaling molecule, such as a hormone or neurotransmitter, binds to a cell surface receptor, it activates a specific G protein, triggering a cascade of events within the cell. These occurrences frequently involve activating or inhibiting enzymes or second messenger systems, which results in changes in cell function. Just like some medications target ion channels, medications can also target G proteins (Yang et al., 2021). They can either activate or inhibit certain G protein-coupled receptors (GPCRs) by modifying their signaling pathways. Beta-blockers, for example, work by blocking GPCRs in cardiac cells, lowering heart rate and blood pressure. Antihistamines, antidepressants, and antipsychotics are all examples of medications that target GPCRs to alter neurotransmitter signaling.

While ion channels primarily regulate ion movement across cell membranes, G proteins act as signal transducers for a wide range of cellular responses initiated by GPCRs. Both ion channels and G proteins are essential components of cellular signaling pathways and are targeted by medications for therapeutic interventions.

 

Patient Question Response

Genetic, environmental, and lifestyle factors all play a role in mental illness. Although genetics does influence the likelihood of mental health disorders, sharing your grandmother’s genes does not necessarily mean that you will experience the same illness. Stress, trauma, and lifestyle decisions are examples of environmental factors that have a substantial impact on the development and course of mental health disorders (Elliott & Ragsdale, 2023). Even in cases where there is a genetic predisposition, risk can be reduced by positive relationships, leading a healthy lifestyle, and managing stress. If you are worried about your mental health, it may be beneficial to speak with a mental health provider who can assist you in determining your specific risk factors and developing methods to preserve excellent mental health. Regular appointments with a mental health expert can also help you monitor and manage your mental health.

References

Cen, J., Hu, N., Shen, J., Gao, Y., & Lu, H. (2024). Pathological functions of lysosomal ion channels in the central nervous system. 
International Journal of Molecular Sciences
, 
25
(12), 6565. 
https://doi.org/10.3390/ijms25126565
Links to an external site.

Elliott, M., & Ragsdale, J. M. (2023). Nature and/or nurture: Causal attributions of mental illness and stigma. 
Social Psychology Quarterly
, 
87
(2), 175–196. 
https://doi.org/10.1177/01902725231175279
Links to an external site.

Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., Liu, Q., Zhao, S., Shui, W., Jiang, Y., & Wang, M.-W. (2021). G protein-coupled receptors: Structure- and function-based drug discovery. 
Signal Transduction and Targeted Therapy
, 
6
(1). 
https://doi.org/10.1038/s41392-020-00435-w
Links to an external site.

Expand discussion thread from Sharon Harrison

2 Replies, 2 Unread

2 Replies, 2 Unread

Reply to post from Sharon Harrison
Reply

Mark as Unread
Mark as Unread

TS

Taryn Rae Skiles

Aug 28, 2024 2:30pm

Reply from Taryn Rae Skiles

​
Signal transduction and the targets of medications consist of several processes. The process of signal transduction is intent on getting the message across the cell membrane to the targets for medications, which are receptors. These receptors are where medications produce their beneficial effects on various disease processes (
Yakubovich, 2024
). Ion channels and g-protein coupled receptors (GPCR) are two important parts of signal transduction. The ion channel is the end target in numerous regulatory pathways. These pathways are initiated by g-protein coupled neurotransmitters and hormones (
Sriram & Insel, 2019
). The g-protein is a metabotropic receptor. It is an intermediate protein that is activated by a neurotransmitter and in return influences the opening of the ion channels and signals a cascade within the cell (
Yakubovich, 2024
). In many cases, GPCR can be inhibitory to successful medication therapy. In particular in antidepressant therapy, many medications are known to indirectly impact the function of these proteins and impact antidepressant efficacy (
Senese et al., 2018
).

If a patient approached me with concern over her family health history of mental illness and her susceptibility, I would first commend the patient for their self awareness of the situation. Additionally, it is important to explain to the patient that there are several factors that impact having a mental illness. While genetics are a factor in some mental illness diagnoses, I would explain that physical health, environment, socioeconomic status, substance abuse and past trauma can all contribute to the onset of mental illness. Lastly, I would explore what particular mental illness their grandparent has because there are direct genetic correlation for certain mental health disorders such as schizophrenia (
Kendall et al., 2024
).

​References

Kendall, K., Duffin, D., Doherty, J., Irving, R., Procter, A., & Walters, J. (2024). The translation of psychiatric genetic findings to the clinic. 
Schizophrenia Research
, 
267
, 470–472. https://doi.org/10.1016/j.schres.2023.10.024

Senese, N. B., Rasenick, M. M., & Traynor, J. R. (2018). The role of g-proteins and g-protein regulating proteins in depressive disorders. 
Frontiers in Pharmacology
, 
9
. https://doi.org/10.3389/fphar.2018.01289

Sriram, K., & Insel, P. A. (2019). G protein-coupled receptors as targets for approved drugs: How many targets and how many drugs? 
Molecular Pharmacology
, 
93
(4), 251–258. https://doi.org/10.1124/mol.117.111062

Yakubovich, D. (2024). Editorial: Direct modulation of ion channels by g-proteins. 
Frontiers in Physiology
, 
15
. https://doi.org/10.3389/fphys.2024.1465766

Reply to post from Taryn Rae Skiles
Reply

Mark as Unread
Mark as Unread

EU

Emilia Uche

Aug 28, 2024 1:15pm

Reply from Emilia Uche

                                                  
 Difference between Ion Channels and G-proteins

Ion Channels
:

Definition
: Ion channels are membrane proteins that produce pores in the cellular membrane that permit ions to flow through.

Function: When ion channels are activated, a selective transmembrane pore opens, enabling ions to diffuse into or out of cells according to their electrochemical gradient. Exogenous drug molecules can modify ion channels, subject to several signaling pathways’ control.

Illustrations: Certain ligand molecules attach to receptor proteins to cause ligand-gated ion channels, such as glutamate, GABAA, and acetylcholine receptors, to open. Changes in membrane potential cause voltage-gated ion channels to open and close.

Clinical Relevance: To affect cellular reactions, several medications target ion channels. More than 170 ion channel medications are available; some are WHO Essential Medicines.

G Proteins
:

Definition
: Membrane proteins known as G proteins are essential for signal transduction because of their interactions with cell-surface receptors.

Activation: The corresponding G protein is activated when a ligand attaches to a G-protein-coupled receptor (GPCR).

Function: The activated G protein may contact an ion channel or an enzyme in the membrane. G proteins can recognize a variety of ligands, including photons, tiny molecules, and proteins.

Clinical Relevance: A variety of drugs target GPCRs. Because of their ability to either amplify or attenuate impulses, they are crucial for preserving physiological homeostasis.
 Mental Illness and Genetics

While genetic predisposition does not ensure that you will suffer from the same mental disease as your grandmother, genetics does play a major influence on the likelihood of having some mental illnesses.

Genetic Impact: With your grandma, you share about half of your DNA with each of your biological parents. If your grandmother had a genetic mental disorder, you might have inherited some of her genes.

Complex Interplay: A mix of genetic, environmental, and lifestyle variables contribute to the development of mental diseases, which are multifactorial. Genetic predisposition interacts with other factors to generate mental disease; it is not a sufficient cause on its own.

Other Factors: Environment: Your upbringing, experiences in life, surroundings, and pressures all have a significant impact on your mental health. An atmosphere that is caring and helpful can lessen the danger, even if you are genetically predisposed.

Epigenetic: Variations in gene expression that take place without changing the DNA sequence are known as epigenetic alterations, and they can affect gene expression. Stress, nutrition, and way of life can all affect these changes.

Unique Deviation:

Non-deterministic: Mental diseases are widely variable, while genetics provides a foundation. While some people without genetic risk factors have mental illness, others who do have risk factors do not.

Resilience: Coping strategies, protective variables, and resilience factors all come into play. Some people have a certain resilience that allows them to handle challenges better than others.

Seek Expert Advice: Speak with a Healthcare Provider: Consult a mental health professional for advice if you are worried about your mental health. They can evaluate your risk factors, talk to you about safeguards, and offer advice.

Early Intervention: It’s important to raise awareness and act early. Frequent evaluations for mental health can aid in spotting any new problems.

Conclusion

In conclusion, G proteins identify a variety of ligands and use intracellular signaling pathways to modify ion channels or other cellular activities. Ion channels, on the other hand, immediately let ions pass through their pores upon ligand binding. Comprehending these distinctions is crucial in creating pharmaceutical substances that could enhance or reduce signaling in diverse physiological settings. Recall that awareness and knowledge are liberating. It can be very different to know your family history and take proactive measures for your mental health. Even though your grandmother and you have similar DNA, your journey is different, and you may take some actions to support mental health.

References

Stevens, E. B., & Stephens, G. J. (2024). Ion Channels as Targets in Drug

Discovery: Outlook and Perspectives. 
Springer EBooks
, 1–34.

https://doi.org/10.1007/978-3-031-52197-3_1
Links to an external site.

Rehman, S., & Dimri, M. (2020). 
Biochemistry, G Protein Coupled

             Receptors
. PubMed; StatPearls Publishing.

https://www.ncbi.nlm.nih.gov/books/NBK518966/
Links to an external site.

DASCAL, N. (2001). Ion-channel regulation by G proteins. 
Trends in

            Endocrinology and Metabolism
, 
12
(9), 391–398.

https://doi.org/10.1016/s1043-2760(01)00475-1
Links to an external site.

Andreassen, O. A., Hindley, G. F. L., Frei, O., & Smeland, O. B. (2023). New

insights from the last decade of research in psychiatric genetics:

discoveries, challenges and clinical implications. 
World Psychiatry
,

22
(1), 4–24. https://doi.org/10.1002/wps.21034

‌

Reply to post from Emilia Uche
Reply

Mark as Unread
Mark as Unread

Ysamar F Lozano

Aug 28, 2024 12:40pm
| 
Last reply Sep 1, 2024 1:54pm

Reply from Ysamar F Lozano

Difference Between Ion Channels & G Proteins

Ion channels and G proteins are both signal transductions located in the brain
and play significant roles in activating different chemical messengers (Stahl, 2021). Ion channels are proteins that penetrate a cell membrane, which can help generate the cell’s electrical activity and allow other ions to enter the membrane (Dai, 2023). Ion channels are a part of the signal transduction process through electrical activity that can aid in a trigger response, such as sodium channels opening that leads to depolarization and begins the process of action potential (Dai, 2023). Ion channels are responsible for the functions of the endocrine, cardiovascular, nerve, and immune systems that can later help to target such areas for treatment (Ohya, 2023). Some medications target ion channels to help treat certain diseases. For example, calcium channel blockers help to treat patients with hypertension by preventing calcium from entering the membrane and relaxing the vascular smooth muscle (McGivern & Ding, 2020).

On the other hand, G proteins act through the signal transduction process by inhibiting or activating proteins in the cell when a ligand links to G protein-coupled receptors (GPCRs) outside of the cell surface (Stahl, 2021). GPCRs have been closely linked to antipsychotic medications such as Abilify, Seroquel, and Zyprexa (Komatsu et al., 2019). The two main receptors that antipsychotic medications target is dopamine receptors, which are types of GPCRs (Komatsu et al., 2019). The dopamine receptors have two main classes, D2, D1, and D4. Different antipsychotic medications target D2 receptors through the process of an antagonist, which blocks D2 receptors (Komatsu et al., 2019). This inhibits symptoms of delusions and hallucinations.

 
Patient Question

            
When answering the patient’s question of having the same mental illness gene from her grandmother, I would explain to the patient that they have a likelihood of being predisposed to such a gene due to being a close relative. For example, suppose a family member has a history of having a mental illness of either bipolar or schizophrenia. In that case, that family relative is six to eight times more likely to develop either illness compared to someone who does not have a family relative who has one of the mental illnesses (Andreassen et al., 2023). However, being genetically predisposed is not always guaranteed, and other external factors may contribute to such mental illness. A mental illness can oftentimes be developed not only genetically but environmentally as well. This theory has been derived from diathesis-stress model, which is when a mental illness is developed from genetic predisposition but also with stressful conditions as well (APA, 2018). Environmental factors can include stress from life events, trauma/PTSD, or even abusing substances. If this patient is worried about having the same mental illness gene like her grandmother, I would advise the individual to seek out professional help early on rather than waiting a prolong amount of time.

 

Reference

American Psychological Association [APA]. (2018, April 19). APA Dictionary of Psychology. Retrieved on August 28, 2024, from https://dictionary.apa.org/diathesis-stress-model

Andreassen, O. A., Hindley, G. F. L., Frei, O., & Smeland, O. B. (2023). New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. 
World psychiatry : official journal of the World Psychiatric Association (WPA)
, 
22
(1), 4–24. https://doi.org/10.1002/wps.21034

Dai, G. (2023). Signaling by Ion Channels: Pathways, Dynamics and Channelopathies. 
Missouri Medicine
, 
120
(5), 367–373.

Komatsu, H., Fukuchi, M., & Habata, Y. (2019). Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders. 
International journal of molecular sciences
, 
20
(13), 3207. https://doi.org/10.3390/ijms20133207

McGivern, J. G., & Ding, M. (2020). Ion Channels and Relevant Drug Screening Approaches. 
SLAS Discovery : Advancing Life Sciences R & D
, 
25
(5), 413–419.     https://doi.org/10.1177/2472555220921108

Ohya, S. (2023). Recent Developments in Ion Channel and Ion-Related Signaling. 
International journal of molecular sciences
, 
24
(19), 14419. https://doi.org/10.3390/ijms241914419

Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press

Discussion Md 1-1.docx

Expand discussion thread from Ysamar F Lozano

1 Reply, 1 Unread

1 Reply, 1 Unread

Reply to post from Ysamar F Lozano
Reply

Mark as Unread
Mark as Unread

California, Arizona Virginia APRN board of nursing state licensure comparison

There are four distinct Advanced Practice Registered Nurse (APRN) roles: nurse practitioner (NP), certified nurse midwife (CNM), clinical nurse specialist (CNS), and certified nurse anesthetist (CRNA). Each type of APRN plays a unique and vital role in healthcare, with specialized training and expertise that enhances patient care across various settings (Bosse, J. et al. (2017). APRNs are often primary care providers and are at the forefront of providing preventive care services to the public. They treat and diagnose illnesses, advise the public on health issues, manage chronic disease, and engage in continuous education to remain ahead or other developments in the field according to nursingoutlook.org. (n.d.). 
 

This discussion topic is between California and Arizona NPs scope of practice. According to California Association for Nurse Practitioners, nurse practitioner in California is an advanced practice registered nurse who has completed graduate level education like master’s or a doctoral degree. To get a license to practice in California, NPs must complete an accredited NP program and be certified by the Board of Registered Nursing (BRN). NPs specialized in many areas including Family/individual across lifespan; Adult-gerontology, primary care, or acute care; Neonatal; Pediatrics, primary care, or acute care; Women’s health/gender related; and Psychiatric-Mental Health across the lifespan as per California Board of Nursing, (n.d.).
 

In California, NPs categories are under Restricted Practice Authority State. In restricted practice states, nurse practitioners must work under the supervision of a physician for all their scope of practice, nursejournal.org. (n.d.). While they may have extensive autonomy in some nurse practitioner functions, they are not acting as independent practitioners, nursejournal.org, (n.d.). However, in California, restrictions may loosen as the NP gains experience, nursejournal.org. (n.d.). 
 

In September 2020, as presented in California Board of Nursing, Governor Gavin Newsom signed Assembly Bill (AB) 890 (Wood, Chapter 265, statutes 2020) into law which created two new categories of Nurse Practitioners (NP) that can function within a defined scope of practice without standardized procedures. These new categories of NPs are 103NP and 104NP. 103 NP works under the provisions outlined in Business and Profession code 2837.103, California Board of Nursing, (n.d.). This NP works in a group setting with at least one physician and surgeon within the population focus of their national certification. 104 NP works under the provisions outlined in Business and Profession code section 2837.104, California Board of Nursing, (n.d.). This NP may work independently within the population focus of their national certification. The law was in effect last January 2023 and according to the Board of California Nursing, 103NP application is now live in BreEZe. 
 

The law requires a licensee to first work as a 103NP in good standing for at least 3 years prior to becoming a 104NP. The Board is only able to certify 103NPs currently and will not be able to certify 104NPs until 2026. According to rn.ca.gov., (n.d.), progress to 
103NP or 104NP is not required; it is just an option. The traditional role of the NP in California remains. NPs can continue to work under physician supervision with standardized procedures in their existing settings, California Board of Nursing, (n.d.).
 

An example scenario where California NP must have a collaborative agreement or standardize procedure that defines their scope of practice, including which conditions or treatments require physician input: A patient presents with feeling of dizziness, irregular heartbeat, and sudden shortness of breath, with history of Congestive Heart Failure. The NP evaluates the patient and suspects a possible pulmonary embolism. According to the collaborative agreement, the NP consults with the physician for further assessment and for hospital admission to acute care. This practice ensures comprehensive care and safety of the patient. 
 

PLACE YOUR ORDER HERE

On the other hand, Arizona Registered Nurse Practitioners (RNPs) have Full Practice Authority. According to nursejournal.org. (n.d.), in full practice states, nurse practitioners can perform the full scope of practice without supervising or collaborating with physicians. They can diagnose a patient, order tests, prescribe medication, and operate their own independent practices, azbn.gov. (n.d.). As per azbn.gov. (n.d.), RNPs means registered nurse who is certified by the board, completed nurse practitioner education program approved or recognized by the board, has an expanded scope of practice within a specialized area of education the RNP has prepared for. 
 

In addition, the Nurse Practice Act defines the scope of practice that an RNPs shall refer a patient to a physician or another health care provider if the referral will protect the health and welfare of the patient and consult with a physician and other health care providers if a situation or condition occurs in a patient that is beyond the RNPs knowledge and experience. 
 

An example scenario of an RNP in Arizona: A 66-year-old male arrives in the clinic for a routine checkup. He has a history of hypertension and type 2 diabetes with uncontrolled A1C, he complains of always feeling tired and he gained weight. The RNP did a thorough assessment, vital signs, checking laboratory results and talking to him about his lifestyle. The RNP adjusted the patient’s meds and upon talking to him patient expressed feeling low and depressed, the RNP did a referral to a mental health counselor. During this visit, the RNP took time in discussing his findings with the patient and how to manage his condition at home. A follow up visit has been scheduled. Based on this scenario, the RNP took an integrated approach in taking care of the patient. This shows the Arizona RNP can manage independently chronic stable conditions in their state of practice.
 

According to Capitol beat blog of American Nurses Association, the ANA supported by a growing body of evidence of the safe and cost-effective provision of care by APRNS, that there is a NATIONAL CALL to remove all barriers to Full Practice Authority from organizations such as the Institute of Medicine (IOM), the Federal Trade Commission (FTC), the National Governors Association (NGA), the Bipartisan Policy Center, and the Veterans Health Administration (VHA), among others. 
 

“FULL PRACTICE AUTHORITY” is defined as an APRNs ability to utilize knowledge, skills, and judgment to practice to the full extent of their education and training, nursingworld.org, (n.d.). Since the requirements such as mandated collaborative practice agreements (CPAs) and physician-supervised transition-to-practice periods still exist, APRNs cannot fully fill the gaps in the needs of our healthcare system and deter them to work in their full capacity, nursingoutlook.org. (n.d.). As APRNs continue to show their competence and compassion to our community, slowly we earn the trust and confidence of the patients we see, and it can transcend to our decision makers that approve the laws and regulations of Advanced Practice Registered Nurse. We are getting there but we must act now by showing them our comprehensive and holistic approach in treating patients in whatever specialty we choose.
 

References
 

AZBN. (2020). 
Arizona Board of Nursing Scope of Practice APRN Questions & Answers SCOPE OF PRACTICE Nurse Practitioners
. 
https://www.azbn.gov/sites/default/files/2020-11/FAQs%20Final%20Questions-%20NP%207.24.20%20%281%29.pdf
Links to an external site.
 
 

Bosse, J., Simmonds, K., Hanson, C., Pulcini, J., Dunphy, L., Vanhook, P., & Poghosyan, L. (2017). 
Position statement: Full practice authority for advanced practice registered nurses is necessary to transform primary careLinks to an external site.
Links to an external site.
. 
Nursing Outlook, 65
(6), 761–765. 
 

California Association
 for Nu
rse Practitioners. (n.d.).
 What is an NP? 
Canpweb.org. 
https://canpweb.org/About/What-is-an-NP
Links to an external site.
 

California Board of Registered Nursing. (2022). 
Assembly Bill 890
. California Board of Registered Nursing. 
https://www.rn.ca.gov/practice/ab890.shtml
Links to an external site.
 
 

Capitol Beat – From the American Nurses Association. (n.d.). 
https://anacapitolbeat.org/
Links to an external site.
 

Feeney, A. (n.d.). 
Nurse practitioner practice authority: A State-by-state guide
. Nurse Journal. 
https://nursejournal.org/nurse-practitioner/np-practice-authority-by-state/
Links to an external site.
 
 

Nursingworld.org. (2017). 
Advanced Practice Registered Nurses (APRN). American Nurses Association. 
https://www.nursingworld.org/practice-policy/workforce/what-isnursing/aprn/#:~:text=Advanced%20Practice%20Registered%20Nurse%20(APRN)
Links to an external site.
  
 

 

California, Arizona Virginia APRN board of nursing state licensure comparison

Professional Nursing and State-Level Regulations

Advanced practice registered nurses (APRNs) include the broader categories of clinical nurse specialists, certified nurse midwives, and nurse anesthetists. Each state has a board of nursing regulations that define nursing practitioners’ roles. The regulations also define the scope of practice and professional activities that each nurse offers based state’s board of nursing regulations. This discussion gives a detailed analysis of the APRN regulations in Virginia and California.

Virginia regulations

Licensing and education
: The Virginia Board of Nursing allows the licensing of nurse practitioners with five years of experience (VBON, n.d). They should have completed a bachelor of nursing degree, hold an active registered nurse license and pass the national certification exam.

Practice authority
: In Virginia, nurse practitioners have restricted practice authority, meaning they are supervised of physicians in all areas of practice (Clarke, 2023). They have some autonomy as nurse practitioner after five years of experience but APRNs cannot be allowed to act independently.

California regulations

Licensing and education
: The California Board of Nursing requires APRNs to have satisfactorily completed a bachelor’s degree in nursing in specific roles, such as midwives or nurse practitioners, and should have passed the National certification exam.

Practice authority
: In California, nurses have full practice authority, thus they can perform their scope of practice as nurse practitioners with zero supervision or collaboration with physicians (Clarke, 2023). Nurse practitioners can independently diagnose patients, prescribe medication and order tests.

Differences

Collaboration aspects
:

In Virginia, APRNs must practice under the supervision of a physician, but after five years of experience, they become flexible and can work independently. However, in California, the standardized procedure for ARPNs is to collaborate with other healthcare professionals throughout their careers, even after extensive experience California, Arizona Virginia APRN board of nursing state licensure comparison.

Independence 

In Virginia, APRNs only become independent to make their own decisions and carry out full-time clinical practice after five years of experience, but California nurse practitioners get additional training to carry out clinical practice independently without a time limit.

Application

The difference in regulations between the two States shows that nurses will carry out their clinical roles differently. In Virginia, APRNs have restricted practice authority; hence, there must be a close working relationship with doctors, as they are required to approve any decisions nurses make (Smith, 2024). The nurses do not have the autonomy to make their own decisions. For example, when treating patients with asthmatic conditions, they must consult with a pulmonologist on the best treatment to use. In California, the ARPNs have full practice authority and hence work independently, depending on their experience and training. When treating patients with asthmatic conditions, they can administer the nebulizer treatment process to patients without consultation with physicians (Clarke, 2023). They have the autonomy to carry out patient examinations, conduct diagnoses, and make drug prescriptions. The nurses can manage all patients’ health challenges without consulting the physician for assistance. Thus, the two states depict how boards of nursing regulations can affect the clinical practice of APRNs.

Conclusion

The board of nursing issue regulations on how APRNs works and their practice in clinical activities. Each state has different regulations on how they use their knowledge and experience and how they collaborate with other healthcare professionals. In Virginia, APRNs have restricted practice, meaning they must collaborate with physicians until they become flexible after five years of practice. In California, APRNs have full practice authority, meaning they can perform nurse practitioner roles in full scope without supervision or collaboration with physicians. The difference shows the impacts of each state’s board of nursing regulations on clinical practice California, Arizona Virginia APRN board of nursing state licensure comparison.

 
References

Clarke, E. (2023, November 10). 
Nurse practitioner practice authority: A State-by-state guide
. NurseJournal. https://nursejournal.org/nurse-practitioner/np-practice-authority-by-state/

Smith, K. (2024). 
A state-by-state breakdown of nurse practitioner practice authority laws
. Www.tebra.com. 
https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state
Links to an external site.

Virginia Board of Nursing – Advanced Practice Registered Nurse
. (n.d.). Virginia Board of Nursing. https://www.dhp.virginia.gov/Boards/Nursing/PractitionerResources/AdvancedPracticeRegisteredNurse/ California, Arizona Virginia APRN board of nursing state licensure comparison

Ion Channels vs. G Proteins in Signal Transduction and Medication Targets

Ion Channels:

Ion channels are proteins that are in the cell membrane which facilitates the passage of ions in and out of the cell. They enable important physiologic processes such as signal transduction, they also react to particular  stimuli such as voltage changes or ligand binding. When these channels are activated, they open to allow ions such as sodium (Na+), potassium (K+), calcium (Ca2+), or chloride (Cl-) to pass through, altering the cell’s electrical state and initiating various cellular responses. Ion channels are also important targets for medications. For instance, calcium channel blockers, which are often used to treat high blood pressure, work by preventing calcium from entering heart and blood vessel muscle cells, leading to decreased heart contractility and blood vessel dilation (Benarroch, 2019).

G Proteins:

G proteins are proteins inside cells that act like switches, turning signals on or off. They help transmit messages from outside the cell, like hormones or neurotransmitters, to the inside. This process starts when these signals bind to special receptors on the cell surface, known as G protein-coupled receptors (GPCRs). When a signal binds to a GPCR, it activates the G protein by swapping a molecule called GDP for another called GTP on a part of the G protein called the α-subunit. When G proteins are activated, they interact with other proteins inside the cell, such as adenylate cyclase or phospholipase C. These proteins then produce molecules called secondary messengers, like cAMP or IP3, which carry the signal further inside the cell. This leads to various responses within the cell. Because GPCRs and G proteins are involved in many important body processes, they are key targets for many drugs. For example, medications like beta-blockers and angiotensin receptor blockers (ARBs) work by affecting these pathways to treat conditions like high blood pressure and heart disease (Skolnick & Volkow, 2020).

Differences in Medication Targeting

Target Mechanism:

Ion Channels: Medications targeting ion channels directly modulate the flow of ions across the membrane. For example, anesthetics such as lidocaine block sodium channels to prevent pain signals (Hille, 2018).

G Proteins: Drugs targeting G protein pathways typically act on the receptors that activate these proteins or on the signaling pathways they regulate. For example, antihistamines block histamine receptors, which are GPCRs, to reduce allergy symptoms (Skolnick & Volkow, 2020).

Speed of Action:

Ion Channels: The effects of ion channel-targeting drugs are often immediate, as they directly alter ion flow and membrane potential, which can quickly change cell activity (Benarroch, 2019).

G Proteins: The effects of drugs targeting G protein pathways can be slower because they often involve multiple steps, including the production of second messengers and the activation of downstream signaling pathways (Thal et al., 2018).

Specificity:

Ion Channels: Drugs targeting ion channels can be highly specific, affecting only one type of ion channel (e.g., calcium channel blockers), but there is a risk of off-target effects on similar ion channels in different tissues (Hille, 2018).

G Proteins: Since G protein pathways are involved in numerous physiological processes, drugs targeting these pathways can have widespread effects, sometimes leading to more side effects (Skolnick & Volkow, 2020).

Understanding Genetic Risk and Mental Illness:
 Having a relative with a mental illness, such as a grandmother, does increase your risk of developing a similar condition, but it does not guarantee that you will. Mental illnesses are complex and result from a combination of genetic, environmental, and lifestyle factors (Choi et al., 2020)

Genetic Factors:
 You share about 25% of your genes with your grandmother, which means you have inherited some genetic material from her. However, mental illnesses like depression, anxiety, bipolar disorder, and schizophrenia are influenced by multiple genes, each contributing a small amount to the overall risk (Levey et al., 2021). In addition to genetics, other factors such as your environment, life experiences, and personal behaviors play a significant role in whether you develop a mental illness (Gandal et al., 2018).

Environmental and Lifestyle Influences:
 Environmental factors, such as stress, trauma, and lifestyle choices (like diet, exercise, and substance use), interact with your genetic predisposition. Even if you have a higher genetic risk, maintaining a healthy lifestyle, seeking support when needed, and managing stress can reduce the likelihood of developing a mental illness (Gandal et al., 2018).

Protective Measures:
 Awareness of your family history allows you to take proactive steps in managing your mental health. Regular check-ins with a mental health professional, staying connected with a supportive community, and practicing self-care are all important strategies.

References

Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., … & CGTP Collaborators. (2021). The concise guide to pharmacology 2021/22: G protein-coupled receptors. British Journal of Pharmacology, 178(Supplement 1), S27-S156. https://doi.org/10.1111/bph.15434

Benarroch, E. E. (2019). Ion channels in neurological diseases: An update. Neurology, 92(6), 541-549. https://doi.org/10.1212/WNL.0000000000006910

Choi, K. W., Zheutlin, A. B., Karlson, R. A., Wang, M. J., Dunn, E. C., Stein, M. B., … & Smoller, J. W. (2020). Mapping the genetic architecture of major depression in the context of environmental risk: Leveraging both linkage-disequilibrium-dependent and -independent SNP heritability. 
American Journal of Psychiatry
, 
177
(10), 917-927. https://doi.org/10.1176/appi.ajp.2020.19030310

Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C & Geschwind, D. H. (2018). Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. 
Science
, 
359
(6376), 693-697. https://doi.org/10.1126/science.aad6469

Hille, B. (2018). Ion channels of excitable membranes (3rd ed.). Sinauer Associates.

Levey, D. F., Polimanti, R., Cheng, Z., Zhou, H., Nunez, Y. Z., Jain, S & Gelernter, J. (2021). Genetic associations with suicide attempt severity and genetic overlap with major depression. 
American Journal of Psychiatry
, 
178
(9), 853-862. https://doi.org/10.1176/appi.ajp.2021.21030228

Skolnick, P., & Volkow, N. D. (2020). G protein-coupled receptors as targets for drug discovery in neuropsychiatric disorders. Neuropsychopharmacology, 45(1), 27-37. https://doi.org/10.1038/s41386-019-0464-6

Thal, D. M., Glukhova, A., Sexton, P. M., & Christopoulos, A. (2018). Structural insights into G-protein-coupled receptor allostery. Nature, 559(7712), 45-51. https://doi.org/10.1038/s41586-018-0245-2

Wray, N. R., Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A & Sullivan, P. F. (2018). Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. 
Nature Genetics
, 
50
(5), 668-681. https://doi.org/10.1038/s41588-018-0090-3

Ion Channels and G Proteins 

This Discussion will allow you the opportunity to engage with your peers to explore the difference between ion channels and G proteins. You will be able to apply this understanding to a specific patient question. Additionally, please reply to your peers with additional information and sources to either support or challenge responses. 

Resources

 

Be sure to review the Learning Resources before completing this activity.

Click the weekly resources link to access the resources. 

WEEKLY RESOURCES

To prepare:

Review the Required Learning Resources.

Consider the difference between ion channels and G proteins.

By Day 3 of Week 1

Post
 a response answering the following:

Explain the difference between ion channels and G proteins as they relate to signal transduction and targets of medications.

How would you answer the following patient question:

My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?

Note: 
Your response needs to be supported and validated by three (3) scholarly peer-reviewed resources located 
outside
 of your course Learning Resources.

Upload a copy of your discussion writing to the draft Turnitin for plagiarism check.  Your faculty holds the academic freedom to not accept your work and grade at a zero if your work is not uploaded as a draft submission to Turnitin as instructed.

Read 
a selection of your colleagues’ posts.

By Day 6 of Week 1

You are required to participate in the Discussion on at least 3 different days (a different day for main post and each response). It is important to adhere to the weekly time frame to allow others ample time to respond to your posting.

Read 
a selection of your colleagues’ posts
.  Respond
 to 
at least two
 of your colleagues on 
2 different days
 by supporting or expanding on their explanation, as well as how they have described their response to the patient.

Peer responses should include at least two (2) supporting scholarly, peer-reviewed references 
outside
 of the provided Learning Resources. Your responses should also include additional resources to either support or refute the responses and should demonstrate critical thinking.

Note:
 Be sure you work to share additional perspectives on the details described by your colleague. Responses of “I agree” or “good point” will result in lower score grading.

Difference Between Ion Channels and G Proteins

Ion channels and G proteins both play critical roles in signal transduction but function differently. Ion channels are proteins embedded in the cell membrane that allow specific ions (like sodium, potassium, or calcium) to pass through the membrane in response to a signal, such as a neurotransmitter. This movement of ions changes the electrical charge of the cell, leading to rapid cellular responses. Ion channels are often targets for medications that require fast-acting effects, such as anesthetics or anti-seizure drugs (Hille, 2018).

G proteins, on the other hand, are involved in more complex signal transduction pathways. When a signaling molecule, such as a hormone, binds to a G protein-coupled receptor (GPCR) on the cell surface, it activates the G protein inside the cell. This activation triggers a cascade of intracellular events, affecting processes like metabolism, gene expression, and cell growth. G protein pathways are targets for drugs that modulate longer-term processes, such as beta-blockers for heart conditions or antipsychotics (Rosenbaum et al., 2020).

Targets of Medications

Both ion channels and G proteins are targets of various medications. For example, calcium channel blockers target ion channels to treat hypertension and heart disease (Smoller, 2019). In contrast, beta-blockers target GPCRs, which activate G proteins, to treat anxiety and hypertension.

Regarding your question, having the same genes as your grandmother does not guarantee you will develop the same mental illness. While genetics play a role in mental health, environmental factors, epigenetics, and gene expression also influence disease susceptibility (National Institute of Mental Health, 2020). A study published in the Journal of Psychiatric Research found that genetic factors contribute to the risk of developing mental illnesses, but environmental factors also play a crucial role (Smoller, 2019). Another study published in Nature Genetics highlighted the importance of gene-environment interactions in mental health (Sullivan et al., 2020). A review published in the Journal of Clinical Psychology emphasized the need to consider both genetic and environmental factors when assessing mental health risk.

In conclusion, Ion channels and G proteins differ in their roles within cellular communication, impacting how medications target these pathways. Ion channels work quickly by allowing ion flow, while G proteins initiate complex, longer-lasting responses. Regarding mental illness, while genetics contribute to risk, they are not the sole cause, and environmental factors play a significant role in determining whether one develops a condition. Understanding these differences can lead to better health outcomes through targeted treatment and informed healthcare choices.

 

 

References

Hille, B. (2018). 
Ion Channels of Excitable Membranes
 (3rd ed.). Sinauer Associates.

National Institute of Mental Health. (2020). 
Genetics and Mental Health.
 https://www.nimh.nih.gov/health/topics/genetics-and-mental-health/index.shtml

Rosenbaum, D. M., Rasmussen, S. G., & Kobilka, B. K. (2020). The structure and function of G-protein-coupled receptors. 
Nature
, 459(7245), 356-363.

Smoller, J. W. (2019). The Genetics of Stress-Related Disorders: PTSD, Depression, and anxiety disorders. 
Neuropsychopharmacology
, 44(1), 130-146.

Sullivan, P. F., Daly, M. J., & O’Donovan, M. (2020). Genetic architectures of psychiatric disorders: The emerging picture and its implications. 
Nature Reviews Genetics
, 13(8), 537-551.

 

Reply from 

To understand how signals are transduced and how they target medications, we must understand what ion channels and G proteins are and how they function.

Ion channel receptors are receptors that open sodium or calcium channels through transducing electrical impulses into chemical signals allowing for some inorganic ions to pass and not others. Ion channels respond to a variety of stimuli that causes the channels to open including voltage across the membrane (voltage-gated channels), mechanical stress (mechanically gated channels, or binding of ligand (ligand-gated channels) (Alberts et al, 2008).

G protein or Guanosine triphosphate binding proteins are regulatory proteins that control a wide range of biological responses through biochemical reactions that cascades and modifies the function of target protein. The two general classes of G protein include heterotrimeric and monomeric G proteins. Heterotrimeric G proteins are composed of three subunits labeled A, B, and Y which creates a different reactive when each subunit is bonded downstream creating a variety of responses in the target cell. Monomeric G protein also known as small G Protein relay signals from activated cell surface receptors to intracellular targets. There are five subfamilies of monomeric G proteins that carry out different functions (Purves et al, 2001).

Ion channel receptors and g protein have been studied extensively and trialed in targets for creating medications for a desired outcome. Amlodipine besylate which is a calcium channel blocker was patented in 1982 and is one of the most widely used anti-hypertensive medications prescribed in the United States is an example of how ion channels may be manipulated for a desired effect. By stimulating the environment, cells are able to communicate with one another to create a desired effect in g proteins which is how clinic drugs are effective in such cases as quetiapine (Seroquel) or olanzapine (Zyprexa) (Raines et al, 2022).

To answer the question of whether a person would have the same mental illness as their grandmother, the answer is not necessarily. While a person may be predisposed to mental illness through genetics, epigenetics modifications during life experiences including chronic stress has been linked to modifications in genes that may lead to anxiety and/or depression. Aside from our genetics, biological pathways may become “activated or silenced” based upon our experiences and therefore will shape our mental health (Grezenko et al, 2023).

 

Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2008). 
Molecular Biology of the Cell.
 Garland Science Taylor & Francis Group. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK26910/

Grezenko, H., Ekhator, C., Nwabugwu, N., Ganga, H., Affaf, M., Abdelaziz, A., Rehman, A., Shehryar, A., Abbasai, F., Bellegarde, S., & Khaliq, A. (2023). 
Epigenetics in Neurological and Psychiatric Disorders: A Comprehensive Review of Current Understanding and Future Perspectives. 
Cureus, 15(8). DOI: 10.7759/cureus.43960

Purves, D., Augustine, G., Fitzpatrick, D., Hall, W., LaMantia, A., & White, L. (2001). 
Neuroscience, 2nd Edition. 
Sinauer Associates. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK10832/

Raines, R., McKnight, I., White, H., Legg, K., Lee, C., Li, W., Lee, P., & Shim, J. (2022). 
Drug-Targeted Genomes: Mutability of Ion Channels  and GPCRs. 
Biomedicines, 10(3), 594. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945769/

Expand discussion thread from Tim Nguyen

2 Replies, 2 Unread

2 Replies, 2 Unread

Reply to post from Tim Nguyen
Reply

Mark as Unread
Mark as Unread

CC

Chineze Christiana Chianakwana

Aug 27, 2024 8:46pm

Reply from Chineze Christiana Chianakwana

Main discussion post:

Ion Channels and G proteins

Ion channels and G proteins are essential constituents of cellular signal transduction, acting in separate capacities and being the focus of different pharmaceutical interventions. Ion channels are membrane proteins that generate pores and facilitate the passage of certain ions (e.g., Na+, K+, Ca2+, and Cl-) across the cell membrane in reaction to stimuli, for example, a voltage change or ligand binding. Such ion transport can quickly modify the cell’s membrane potential and trigger biological reactions. Pharmacological agents such as anticonvulsants inhibit sodium channels to decrease neuronal excitability in epilepsy, and calcium channel blockers in the management of hypertension by vascular relaxation, primarily aim at ion channels (Hille, 2022).

G Proteins, also known as Guanine nucleotide-binding proteins, are intracellular proteins that function as molecular switches in routes of signal transmission. They transmit signals from active cell surface receptors, such as G-protein-coupled receptors (GPCRs), to different effectors within the cells, like enzymes and ion channels. Consequently, second messengers such as cAMP or IP3 can be generated, facilitating the transmission of the signal within the cell (Odoemelam et al., 2020). G protein pathway-targeting drugs like beta-blockers impede GPCR signaling for cardiovascular disease management, and antipsychotics, which regulate dopamine receptor activity for the management of mental illness.

Ion channels and G proteins are of great importance. They are essential constituents of biological signaling, although they operate through distinct mechanisms. For example, ion channels undergo opening or closing in reaction to specific external signals, such as variations in electrical potential or the interaction with a ligand. When in an open state, these membranes permit the passage of specified ions (such as Na+, K+, Ca2+, or Cl-) along their electrochemical gradient (McGivern & Ding, 2020). Conversely, G proteins are stimulated by G protein coupled receptors (GPCRs) upon binding of a ligand to the receptor. Upon activation, the G proteins engage with other intracellular proteins initiating a series of events that ultimately result in a biological response 
(
Odoemelam et al., 2020).

Questions regarding the potential influence of family history on one’s health are reasonable. Although hereditary factors can predispose to some mental disorders, a positive family history of mental illness is not a guarantee that one will ultimately develop the same disorder.  Inheritance of certain genes does not guarantee the inheritance of all the same risk factors, as genetic expression might significantly differ among individuals (Sullivan & Geschwind, 2019).

Genetics is merely one parameter among several predisposing factors to mental disorders. Furthermore, environmental conditions, life events, lifestyle, and unique characteristics also exert substantial influence. Several mental health disorders are intricate and might arise from a confluence of genetic, environmental, and multifactorial influences (Goldin, 2023).

References

Goldin, D.S. (2023). Fast facts for psychopharmacology for nurse practitioners. Springer Publishing

Hille, B. (2022). Ionic channels in nerve membranes, 50 years on. 
Progress in Biophysics and Molecular Biology
, 
169–170
, 12–20. 
https://doi.org/10.1016/j.pbiomolbio.2021.11.003
Links to an external site.

McGivern, J. G., & Ding, M. (2020). Ion channels and relevant drug screening approaches. 
SLAS Discovery
, 
25
(5), 413–419. https://doi.org/10.1177/2472555220921108

Odoemelam, C. S., Percival, B., Wallis, H., Chang, M.-W., Ahmad, Z., Scholey, D., Burton, E., Williams, I. H., Kamerlin, C. L., & Wilson, P. B. (2020). G-protein coupled receptors: Structure and function in Drug Discovery. 
RSC Advances
, 
10
(60), 36337–36348. https://doi.org/10.1039/d0ra08003a

Rockman, H. A., & Lefkowitz, R. J. (2024). G protein–coupled receptors: From radioligand binding to cellular signaling. 
Journal of Clinical Investigation
, 
134
(5). https://doi.org/10.1172/jci178109

Sullivan, P. F., & Geschwind, D. H. (2019). Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders. 
Cell
, 
177
(1), 162–183. 
https://doi.org/10.1016/j.cell.2019.01.015
Links to an external site.

 

Reply from Sabrina Quarmyne

According to the National Cancer Institute (2024), signal transduction is “the process by which a cell responds to substance outside the cell through signaling molecules found on the surface of and inside the cell. Most molecules bind to a specific protein receptor (signaling molecule) on or in a cell. Signal transduction is important for cells to grow and work normally.”

 

Ion channels and G proteins play a role in signal transductions but in different ways. Ion channels are gated permeable pathways that open for a limited time; an activator is needed to open the pathway. It allows specific ion (s) (sodium, potassium, calcium, and chloride) to flow across the membrane. The flow of ions changes the membrane potential, triggering cellular responses. One type of ion channel is the ligand-gated ion channel; the ionotropic receptors have a site where a neurotransmitter can bind, called the binding site. When the neurotransmitter binds (called the ligand), it causes the channel to open the receptor, and ions flow into the neuron (Alberts et al. 2019). “Ion channel signaling is a dynamic process that is essential for various physiological functions, including pain sensation, motor control, and fight or flight responses” (Dai, 2023). Some drugs/disorders that involve ion channels for treatment include cardiac arrhythmias, neuropathic pain, and muscle disorders (Dai, 2023).

 

G protein-coupled receptors (GPCRs) are proteins on the cell surface that conduct signals across the cell membrane. When a neurotransmitter binds to the receptor, it activates a G-protein, which can affect the opening of ion channels and activate signaling molecules, also known as second messengers, which initiate signaling cascades within the cell. The activation of the G protein exchanging GDP to GTP. G proteins regulate cellular responses through second messenger systems like cyclic AMP and phosphoinositide signaling pathways. G protein-coupled receptors (GPCRs) are slower-acting than the ion channels. GPCR activity changes lead to signaling pathway abnormalities affecting cardiovascular diseases, mental disorders, hormonal imbalances, and cancer. Drugs that target CPCRs include histamine receptor blockers, opioid agonists, beta-blockers, and angiotensin receptor blockers (Odoemelam et al., 2020)

 

Suppose a person were to ask if they will get the same mental illness as their grandmother because they have the same genes as her. It is reasonable for someone to have concerns if they will develop the same illness from a family member. Environmental variables (stress or trauma), family dynamics, and lifestyles can also play a factor in mental health illnesses as well as genetics. Although mental illness plays a role in predisposing others to mental health conditions, it is not entirely guaranteed that they may get the exact mental conditions as their grandmother (Whittle et al.2024).

 

References:

Alberts, B., Johnson, A., Lewis, J. (2019). Ion channels and the Electrical Properties of Membranes. 
Molecular
 
Biology of the Cell, 4
th
 edition.
 
https://www.ncbi.nlm.nih.gov/books/NBK26910/
Links to an external site.

Dai G. (2023). Signaling by Ion Channels: Pathways, Dynamics and Channelopathies. 
Missouri Medicine
, 
120
(5), 367–373.

National Cancer Institute (2024). 
Signal Transduction Definition
. 
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/signal-transduction
Links to an external site.

Odoemelam, C., Percival, B., Wallis, H., Chang, M., Ahmad, Z., Scholey, D., Burton, E., Williams. (2020).  G protein-coupled receptors: structure and function in drug recovery. 
Royal Society of Chemistry, 10
(4), 337-348

Whittle, S., Zhang, L., Rakesh,D. (2024). Environmental and neurodevelopmental contributors to youth mental illness. 
American College of Neuropsychopharmacology.  
https://doi.org/10.1038/s41386-024-01926-y
Links to an external site.

 

Expand discussion thread from Sabrina Quarmyne

1 Reply, 1 Unread

1 Reply, 1 Unread

Reply to post from Sabrina Quarmyne
Reply

Mark as Unread
Mark as Unread

Odessa Fry

Aug 27, 2024 4:14pm
| 
Last reply Aug 28, 2024 8:48pm

Reply from Odessa Fry

Discussion Post

Explain the Difference Ion Channel and G Protein Signal Transduction

There are different signal transduction cascades including G-protein-linked systems and ion-channel-linked systems.  Each starts with a diverse first messenger joining a unique receptor conducting activation of different downstream second, third, and so on chemical messengers (Stahl, 2021).  This allows a diverse biological collection of chemical messaging systems. G-protein-linked system and ion-channel-linked system are started by neurotransmitters. These systems prompt genes in the cell nucleus via phosphorylating a protein called CAMP response element binding protein CREB (Bondar, et al., 2020).  The G-protein-linked system works through a flow encompassing protein kinase A (Kostenis, et al., 2024). The ion-channel works across calcium with its capacity to stimulate and ability to activate a different kinase called calcium/calmodulin kinase (Maiorov, et al., 2024).

Regarding Mental Illness Transmission

Genetic evidence suggests that a sizable portion of genetic impacts exceed clinical diagnostic limitations of psychiatric disorders (Ashitha, 2023).  Neurotransmission triggers gene expression by a fast signal transduction that has a coded message that is passed along until the message is delivered to phosphoprotein or DNA.  Neurons alter their function by changing genes that are being turned on and off.  Molecular processes use neurotransmission to manage gene expression.  Genes only occupy a few percent of DNA, but these are essential for structure and regulation of whether a gene is conveyed or not.  The neuronal function deems gene expression is not only defined by numbers but by other circumstances as well.  These gene factors are also thought to underlie actions of psychopharmacological drugs and disorders in the central nervous system. Overall, it is possible for the gene to be transmitted to the granddaughter.

References

Ashitha, S., Ganesh, S., Purushottam, M., Viswanath, B., & Jain, S. (2023). T105. Genetic Influences of Neurodevelopmental Genes on Severe Mental Illnesses. 
European Neuropsychopharmacology
, 75(Supplement 1), S219. https://doi.org/10.1016/j.euroneuro.2023.08.504

Bondar, A., Jang, W., Sviridova, E., & Lambert, N. A. (2020). Components of the Gs signaling cascade exhibit distinct changes in mobility and membrane domain localization upon β2‐adrenergic receptor activation.
 Traffic
, 21(4), 324–332. https://doi.org/10.1111/tra.12724

Evi Kostenis, Lars Jürgenliemke, & Judith Alenfelder. (2024). G protein-mediated signal transduction: a molecular choreography of G protein activation after GTP binding. 
Signal Transduction and Targeted Therapy
, 9(1), 1–3. 
https://doi.org/10.1038/s41392-024-01903-3
Links to an external site.

Maiorov, S. A., Laryushkin, D. P., Kritskaya, K. A., Zinchenko, V. P., Gaidin, S. G., & Kosenkov, A. M. (2024). The Role of Ion Channels and Intracellular Signaling Cascades in the Inhibitory Action of WIN 55,212-2 upon Hyperexcitation. 
Brain Sciences
 (2076-3425), 14(7), 668. 
https://doi.org/10.3390/brainsci14070668
Links to an external site.

Stahl, S. M. (2021). 
Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (
5th ed.). Cambridge University Press
.
 Chapter 1, “Chemical Neurotransmission” (pp. 1–28)

Expand discussion thread from Odessa Fry

1 Reply, 1 Unread

1 Reply, 1 Unread

Reply to post from Odessa Fry
Reply

Mark as Unread
Mark as Unread

AO

Akunna Onwuka

Aug 26, 2024 6:44pm
| 
Last reply Aug 28, 2024 9:54pm

Reply from Akunna Onwuka

Ion channels
 are proteins in cell membranes that open channels for ions—charged particles such as sodium, potassium, calcium, and chloride—to flow through. These channels are critical in nerve and muscle cells for various biological functions.

Numerous physiological processes, such as controlling heart rate, contracting muscles, sending messages through nerves, and preserving homeostasis across cell membranes, depend on ion channels. Channelopathies, which include epilepsy, arrhythmias, and cystic fibrosis, are disorders caused by ion channel dysfunction. (Alexander et al., 2019).

Guanine nucleotide-binding proteins, or G proteins
, are a family of proteins that play a pivotal role in cellular communication. They act as molecular switches in various signaling pathways, including hormones, neurotransmitters, and light and smell, effectively moving information from the cell’s exterior to its interior. ( Duncan et al., 2020).

The difference between ion channels and G proteins relates to signal transduction and medication targets.

Understanding the distinct functions that G proteins and ion channels play in signal transduction is crucial, especially in pharmacology.

Ion Channels
: Membrane proteins called ion channels permit specific ions, such as Na, K, Ca, and Cl, to flow across the cell membrane. They aid in controlling cell electrical activity, especially in excitable tissues like neurons and muscle cells.  An ion channel can be immediately opened or closed to allow ions to enter or exit a cell when a signal, such as a neurotransmitter, attaches. This ion migration modifies the cell’s membrane potential, triggering other cellular reactions or resulting in an action potential (in neurons, for example).  Drugs targeting ion channels usually work by increasing or decreasing ion flow. For instance, sodium channels are blocked by local anesthetics such as lidocaine, which stops nerve impulses from spreading and lessens pain perception. Example: Calcium channel blockers, such as amlodipine, work by lowering the amount of calcium that enters the vascular smooth muscle, which causes vasodilation and the treatment of hypertension.  Ion channels mediate fast reactions because ions flow upon channel opening, and membrane potential changes nearly quickly.( Insel et al., 2019).

On the other hand, in G Proteins,
 G protein-coupled receptors (GPCRs) are surface-located intracellular signaling molecules that interact with G proteins. Various ligands, including neurotransmitters, hormones, and sensory signals, can trigger these receptors.  A GPCR is activated when a ligand attaches to it. This activation of the G protein sets off several downstream signaling pathways. This may result in changes in second messenger levels (cAMP, IP₃, etc.) or indirect ion channel activation. The exact G protein subtype (e.g., Gs, Gi, Gq) determines which pathways G proteins can activate or inhibit.  Many medications operate as agonists or antagonists, depending on the GPCR, to increase or decrease the receptor’s ability to interact with G proteins. For Example, Beta-blockers (such as propranolol) function as antagonists at beta-adrenergic GPCRs to lower blood pressure and heart rate. As an illustration, antipsychotic medications (such as risperidone) frequently modify neurotransmission by acting on dopamine receptors, which are GPCRs.  G protein signaling often takes longer than ion channel-mediated responses due to its many stages and secondary messenger synthesis.

Unlike the immediate, localized reactions observed with ion channels, the consequences can be more extensive and long-lasting.

Ion channels and G proteins are essential targets in pharmacology, and knowing their unique functions aids in forecasting how different drugs will affect the body.( Seyedabadi et al., 2019).

How I would answer the patient’s query regarding whether they will get the same mental illness because her grandmother has a mental illness and she has the same genes as her:

I will start by discussing with her/him that “Having a grandmother or other family member with a mental illness may somewhat raise her risk, but it does not ensure that she will experience the same illness. Combinations of hereditary and non-genetic variables, such as experiences, stress levels, lifestyle, and surroundings, can affect mental health. It does not follow that she will always have the same disease just because she has similar genes. She must prioritize her mental health by engaging in self-care, leading a healthy lifestyle, and, if necessary, obtaining professional assistance. I will also  discuss  the strategies on how she will   support her  mental health and watch for warning signals if  she is  worried.” This method encourages proactive mental health treatment while also offering comfort. (Duncan et al., 2020).

 

 

References

Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters,

J. A.Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J.

Sharman, J. L., Southan, C., Davies, J. A., Abbracchio, M. P., Alexander, W., Al-

hosaini, K., Bäck, M., Beaulieu, J., & Bernstein, K. E. (2019). THE CONCISE

GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors.

             British Journal of Pharmacology
, 
176
(S1).

https://doi.org/10.1111/bph.14748
Links to an external site.

Duncan, A. L., Song, W., & Sansom, M. S. P. (2020). Lipid-Dependent Regulation of

Ion Channels and G Protein–Coupled Receptors: Insights from Structures

and  Simulations. 
Annual Review of Pharmacology and Toxicology
,

               60
(1), 31– 50.

https://doi.org/10.1146/annurev-pharmtox-010919-023411
Links to an external site.
.

 

Insel, P. A., Sriram, K., Gorr, M. W., Wiley, S. Z., Michkov, A., Salmerón, C., & Chinn,

A. M.  (2019). GPCRomics: An Approach to Discover GPCR Drug Targets.

               Trends in 
  Pharmacological Sciences
, 
40
(6), 378–387.

https://doi.org/10.1016/j.tips.2019.04.001
Links to an external site.

 

Seyedabadi, M., Ghahremani, M. H., & Albert, P. R. (2019). Biased signaling of G

protein-coupled receptors (GPCRs): Molecular determinants of

GPCR/transducer selectivity and therapeutic potential. 
Pharmacology &

             Therapeutics
, 
200
, 148–178.

https://doi.org/10.1016/j.pharmthera.2019.05.006

 

Professor and class,

Ion channels and G proteins are both important in signal transduction. The former, are pore-forming proteins embedded in cell membranes that allow the selective passage of ions, such as sodium or chloride, across the membrane (Zheng & Trudeau, 2023, p. 37). This ion movement generates electrical signals in excitable cells like neurons and muscle cells. When a neurotransmitter binds to an ion channel, it can cause the channel to open or close, leading to an immediate change in the cell’s electrical state. As such, medications that target ion channels typically work by modulating this flow of ions, either enhancing or inhibiting the channel’s activity, and are often used to treat conditions like epilepsy, anxiety, and cardiac arrhythmias.

 

On their part, G proteins, are part of a larger signaling pathway that involves G protein-coupled receptors (GPCRs). When a signaling molecule, such as a hormone or neurotransmitter, binds to a GPCR, it activates the associated G protein, which then influences various intracellular signaling pathways (Yang, et al., 2021). This can lead to changes in enzyme activity, gene expression, or ion channel regulation, but these effects are generally slower and protracted compared to the direct actions of ion channels. According to Yang et al. (2021), medications targeting GPCRs and G proteins can modulate these signaling pathways, affecting a wide range of physiological processes. These drugs are commonly used in treating conditions like hypertension, depression, and allergies.

 

In response to the patient’s question, I would let her know that I understand her concerns, and while genetics do play a role in the risk for mental illness, having the same genes as your grandmother does not mean you will definitely develop the same condition. Mental illnesses are influenced by a combination of genetic, environmental, and lifestyle factors (Marees, et al., 2021). Hence, just because your grandmother had a mental illness does not mean you will have it too. It is important to focus on factors you can control, like maintaining a healthy lifestyle, managing stress, and seeking support if you ever need it.

 

References

Marees, A. T., Smit, D. J., Abdellaoui, A., Nivard, M. G., van den Brink, W., Denys, D., . . . Derks, E. M. (2021). Genetic correlates of socio-economic status influence the pattern of shared heritability across mental health traits. 
Nature Human Behaviour, 5
, 1065-1073. 
https://doi.org/10.1038/s41562-021-01053-4
Links to an external site.

Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., . . . Xie, L. (2021). G protein-coupled receptors: Structure- and function-based drug discovery. 
Signal Transduction and Targeted Therapy, 6
(7), e574. 
https://doi.org/10.1038/s41392-020-00435-w
Links to an external site.

Zheng, J., & Trudeau, M. C. (2023). 
Textbook of ion channels.
 Boca Raton, FL: CRC Press.

Hawaii and Guam APRN Board of Nursing licensure Regulations

Here is a comparison between the APRN Board of Nursing regulations in Hawaii and Guam, which I drew from my experience there. Two years ago, I worked in Guam, and currently, I live and practice in Honolulu, Hawaii. This experience gives me a unique perspective on how APRN regulations differ between these locations.

Hawaii grants APRNs Full Practice Authority (FPA), meaning APRNs can practice independently without physician supervision. Key regulations include full autonomy in diagnosing, treating, and managing patient care. The ability to prescribe medications, including controlled substances, without needing a collaborative agreement with a physician (Hawaii Board of Nursing, 2023). For example, in my current practice in Hawaii, APRNs can independently manage patients with chronic conditions like diabetes, adjusting medications and developing care plans without the need for a physician’s approval.

ORDER A PAPER HERE

When I was working in Guam, the regulatory environment was different. APRNs in Guam are required to have a collaborative agreement with a physician, particularly for prescriptive authority. APRNs can diagnose and treat patients but must maintain a formal, documented collaboration with a physician, especially for prescribing controlled substances (Guam Board of Nurse Examiners, 2022) Hawaii and Guam APRN Board of Nursing licensure Regulations. For instance, while APRNS could diagnose conditions like hypertension in Guam, they needed to collaborate with a physician for certain treatment decisions, particularly when prescribing medications like beta blockers or ACE inhibitors.

To compare APRN Board of Nursing regulations in Hawaii and Guam, I’ve focused on two key areas: scope of practice and prescriptive authority. 

Hawaii is one of the states with Full Practice Authority (FPA) for APRNs. This means APRNs can diagnose and treat patients independently without physician oversight. (Hawaii Board of Nursing, 2023). For instance, an APRN in Hawaii can independently manage a patient with diabetes, adjust medication as necessary, and prescribe insulin or other treatments without requiring a physician’s approval. Guam, conversely, requires APRNs to have a collaborative agreement with a physician, particularly when prescribing medications.

APRNs in Guam can diagnose and treat patients, but they need a formal, documented agreement with a collaborating physician. (Guam Board of Nurse Examiners, 2022). In practice, this means that an APRN in Guam treating a hypertensive patient might diagnose the condition independently. Still, they would need to consult with or gain approval from their collaborating physician to prescribe certain antihypertensive medications.

Key Differences:

Scope of Practice: Hawaii provides full autonomy to APRNs, allowing them to practice without needing a physician’s involvement, whereas Guam requires APRNs to maintain a formal collaboration with a physician.

Prescriptive Authority: Hawaii allows APRNs to prescribe all medications, including controlled substances independently. In contrast, Guam restricts prescriptive authority and requires collaboration for prescribing, especially with controlled substances.

Impact on APRNs:

APRNs practicing in Hawaii can fully leverage their education and experience, functioning autonomously in primary, acute, and specialty care. For example, an APRN in Hawaii may run an independent clinic, managing all aspects of patient care, from diagnosis to medication management, without physician oversight. In Guam, APRNs must adhere to the collaborative practice requirements. This means that even though they are skilled and educated, they are legally bound to collaborate with physicians for certain aspects of patient care, particularly when prescribing medications Hawaii and Guam APRN Board of Nursing licensure Regulations.

Example of Adherence: In Hawaii, an APRN could independently open a private practice where they diagnose, treat, and prescribe medication for patients, even handling controlled substances like opioids for pain management. In Guam, an APRN might work within a healthcare clinic where they collaborate with a physician. While APRNs can handle most patient care, they must ensure their prescribing practices align with the collaborative agreement, especially regarding medications requiring physician oversight.

 

References

American Association of Nurse Practitioners (AANP). (2023). State practice environment for APRNs. 
https://www.aanp.org/advocacy/state/state-practice-environment
Links to an external site.

Guam Board of Nurse Examiners. (2022). APRNs in Guam: Regulatory guidelines. Guam Board of Nurse Examiners. 
http://guamboardofnurseexaminers.org/aprn-regulations
Links to an external site.

Hawaii Board of Nursing. (2023). Advanced Practice Registered Nurse licensure requirements. Hawaii Department of Commerce and Consumer Affairs. 
https://cca.hawaii.gov/pvl/boards/nursing/aprn/
Links to an external site.

National Council of State Boards of Nursing (NCSBN). (2023). APRN consensus model: Practice regulations by state. 
https://www.ncsbn.org/aprn-consensus.htm 
 Hawaii and Guam APRN Board of Nursing licensure Regulations

92 y/o African American male is brought to the Emergency Department by his daughter. The
patient has slurred speech. His blood pressure is 210/100

Case Study Assignment: differential diagnoses and diagnostic testing

When seeking to identify a patient’s health condition, advanced practice nurses can use a diverse selection of diagnostic tests and assessment tools to help in understanding a patient’s condition. In turn, beginning with a differential diagnosis supports the process of further applying information to narrow the possibilities of what the condition may be and working to arrive at the most accurate diagnosis for planning treatment.

For this Case Study Assignment, you will determine the physical exams and diagnostic tests that would be most appropriate for gaining information and better understanding of your patient’s condition. Then, based on your analysis, you will formulate a differential diagnosis for the patient.

Resources

 

Be sure to review the Learning Resources before completing this activity.

Click the weekly resources link to access the resources.

WEEKLY RESOURCES

To prepare:

By Day 1 of this week, your Instructor will assign a patient profile for this Assignment. 
Note:
 Please see the 
Course Announcements
 section of the classroom for your patient profile Assignment.

Review this week’s Learning Resources.

Review the details of the patient case study.

Consider what physical exams and diagnostic tests would be most appropriate to gather more information about the patient’s condition.

Reflect on how the results would be used to make a diagnosis.

Identify 
three to five (3–5)
 possible conditions that may be considered in a differential diagnosis for the patient.

Assignment: Diagnostic Reasoning 

Include the following:

Identify the patient’s chief complaint.

Identify what physical exams and diagnostic tests would be most appropriate to gather more information about the patient’s condition. Be specific and explain your reasoning.

Explain how the results would be used to make a diagnosis.

Identify 
three to five (3–5)
 possible conditions that may be considered in a differential diagnosis for the patient. Explain your thinking.

 

92 y/o African American male is brought to the Emergency Department by his daughter. The
patient has slurred speech. His blood pressure is 210/100

Case Study Assignment: Differential Diagnoses and Diagnostic Testing of a 92-Year-Old African American Male

Hypertension is one of the most common non-communicable lifestyle diseases that usually affect persons as they grow older. One of the causes is the inevitable stiffening of the walls of blood vessels through calcification as one ages. Combined with atherosclerosis due to hyperlipidemia, this is because of the higher prevalence of hypertension in the older generation (Barrett et al., 2019; Jameson et al., 2022). The patient discussed in this case is an elderly African American male with a history of hypertension who is non-compliant with taking his medications. On admission to the Emergency Department (ED), his BP is found to be high at 210/ 100 mmHg. The patient was brought by his daughter to the ED, and he presented with slurred speech. According to the Mayo Clinic (2022), dysarthria is a primary symptomatic indication of hemorrhagic stroke that affects the right side of the brain. Dysarthria is a disturbance in spoken speech by the patient as the speech center is impaired by the blood that infiltrates the brain parenchyma after a hemorrhagic stroke occurs. The patient high blood pressure could likely have been caused by non-adherence to his prescription or the ineffectiveness of the current medications he is on.

Background

Dysarthria is caused when neurons that send signals to control the tongue, face, and throat muscles are affected. Therefore, the muscles in these places become poorly coordinated due to the deranged neuronal signaling and weak and slow response (Barrett et al., 2019; Chiaramonte & Vecchio, 2020). The patient’s speech, affected by dysarthria, becomes slurred, slow, and incomprehensible. The increased blood pressure increases artery pressure in the brain, causing them to burst, resulting in hemorrhagic strokes. The neurons in the speech center get compromised; hence, they cannot effectively send nerve impulses to the neuromuscular junction for adequate movement required for speech.

BUY A PLAGIARISM-FREE PAPER HERE

Convenient Diagnostic Tests and Physical Examination for the 92-Year-Old Patient

The brain has membranes that coordinate and send messages regulating our functions.  The brain parenchyma is referred to as subarachnoid hemorrhage or SAH. However, another type of hemorrhagic stroke affects the actual brain parenchyma and, by extension, the speech center and is referred to as intracerebral hemorrhage or ICH (Barrett et al., 2019; Jameson et al., 2022). In this case, it is most likely that the type of hemorrhagic stroke he suffered from was the ICH type. Ball et al. (2023). A physical assessment, including a neuro assessment, is essential to focus on during patient systems assessment.

The neurologic examination will not stop at that but will also assess several neurological signs. A patient who has suffered a hemorrhagic stroke such as this one will usually also display signs that indicate meningeal irritation in the absence of inflammation. These signs indicate meningeal irritation, called meningism (Ball et al., 2023; McCance & Huether, 2019). In this case, a positive Kernig sign and a positive Brudzinski sign indicate the presence of meningismus or nuchal rigidity. A positive Brudzinski sign is elicited when hip flexion is not voluntary as the patient’s neck flexes. On the other hand, pain when the knee is extended as the thigh is bent at an angle of 90 degrees indicates a positive Kernig sign. Other appropriate tests for this patient include an electroencephalogram or EEG, an electrocardiogram or EKG, a chest X-ray, a computed tomography (CT) scan of the brain, and a magnetic resonance image (MRI).

Regarding imaging studies and evidence-based practice (EBP), a CT scan and an MRI should be the first imaging done. In this case, a CT scan gives the neurologist a much broader picture of any brain damage that this patient may have suffered. CT cans are more conclusive in detecting any bleeding in the brain.  In this case, An MRI will also be helpful. Apart from the primary hemorrhage, there will also be subsequent hemorrhages in the form of abnormalities such as cerebral vein thrombosis and cavernomas, amongst others. An MRI will help detect any persistent bleeding, as well as surgeries and treatment plans.

Other Laboratory Blood Tests

Apart from suffering from hypertension, the patient could also be suffering from a variety of coagulation abnormalities and hemorrhagic conditions. Specific blood tests must also be done to measure these and rule them out in the patient. These include prothrombin time or PT (which can be translated to the international normalized ratio or INR), platelet count, and the activated partial thromboplastin time or aPTT amongst others (Jameson et al., 2022; McCance & Huether, 2019). The presence of thyroid antibodies, immunoglobulins, antinuclear antibodies, and the rheumatoid factor must also be quantitatively assessed. This is to rule out other conditions, such as vasculitis. Lastly, liver function tests and a renal profile may have to be performed as well to rule out kidney and liver failure.

Employment of the Tests to Make a Diagnosis

The above tests and investigations would show that this patient has a diagnosis of hemorrhagic stroke. The impaired speech and the elevated blood pressure on assessment also support this diagnosis. Positive aPTT, PT, and INR tests would also point to a disorder of clotting that may have supported the hypertension in causing the stroke. The outcomes of these various tests and evaluations will be interpreted in light of the subjective information already in the clinician’s hands. 92 y/o African American male is brought to the Emergency Department by his daughter. The patient has slurred speech. His blood pressure is 210/100

The Most Probable Differential Diagnoses for the Patient

According to the Mayo Clinic (2022) and Jameson et al. (2022), the other conditions that may also cause dysarthria and get mistaken for hemorrhagic stroke (differential diagnoses) include:

Transient ischemic attack (TIA).

Hypertensive encephalopathy.

Amyotrophic lateral sclerosis or ALS.

The thinking behind this is that these conditions would cause similar dysarthria.

References

Ball, J., Dains, J.E., Flynn, J.A., Solomon, B.S., & Stewart, R.W. (2023).
Seidel’s guide to physical examination: An interprofessional approach, 10
th
ed
. Elsevier.

Barrett, K.E., Barman, S.M., Brooks, H.L., & Yuan, J. (Eds) (2019).
Ganong’s review of medical physiology, 26
th
ed.
McGraw-Hill Education.

Chiaramonte, R., & Vecchio, M. (2020). A systematic review of measures of dysarthria severity in stroke patients.
PM&R, 13
(3), 314-324.
https://doi.org/10.1002/pmrj.12469

Jameson, J.L., Fauci, A.S., Kasper, D.L., Hauser, S.L., Longo, D.L., & Loscalzo, J. (Eds) (2022).
Harrison’s Principles of Internal Medicine, 21
st
ed
. McGraw-Hill Education. 92 y/o African American male is brought to the Emergency Department by his daughter. The patient has slurred speech. His blood pressure is 210/100

Mayo Clinic (2022, May 17).
Dysarthria
.
https://www.mayoclinic.org/diseases-conditions/dysarthria/symptoms-causes/syc-20371994

McCance, K.L. & Huether, S.E. (2019).
Pathophysiology: The biologic basis for disease in adults and children, 8
th
ed
. Mosby/Elsevier.

 

By Day 7 of Week 3 – 
92 y/o African American male is brought to the Emergency Department by his daughter. The
patient has slurred speech. His blood pressure is 210/100

NURS_6512_Week 3_Assignment 1_Rubric

NURS_6512_Week 3_Assignment 1_Rubric

Criteria

Ratings

Pts

This criterion is linked to a Learning Outcome
Identify the patient’s chief complaint. 92 y/o African American male is brought to the Emergency Department by his daughter. The patient has slurred speech. His blood pressure is 210/100

15
 
to >
12.0
 pts
Excellent
The response clearly, accurately, and in detail explains the assigned patient’s chief complaint.

12
 
to >
9.0
 pts
Good
The response accurately explains the assigned patient’s chief complaint.

9
 
to >
6.0
 pts
Fair
The response vaguely and with some inaccuracy explains the assigned patient’s chief complaint.

6
 
to >
0
 pts
Poor
The response is inaccurate and/or missing an explanation of the assigned patient’s chief complaint.

15
 pts

This criterion is linked to a Learning Outcome
Identify what physical exams and diagnostic tests would be most appropriate to gather more information about the patient’s condition. Be specific and explain your reasoning.

20
 
to >
17.0
 pts
Excellent
The response clearly, accurately, and in detail Identifies physical exams and diagnostic tests that are most appropriate to gather more information about the patient’s condition; reasoning for the exams/tests is clear, accurate, and detailed.

17
 
to >
14.0
 pts
Good
The response accurately Identifies physical exams and diagnostic tests that are most appropriate to gather more information about the patient’s condition; reasoning for the exams/tests is specific and accurate.

14
 
to >
13.0
 pts
Fair
The response vaguely and with some inaccuracy Identifies physical exams and diagnostic tests that are appropriate to gather more information about the patient’s condition; reasoning for the exams/tests is vague and somewhat accurate.

13
 
to >
0
 pts
Poor
The response is inaccurate and/or missing identification of physical exams and diagnostic tests that are appropriate to gather more information about the patient’s condition; reasoning for the exams/tests is inaccurate or missing.

20
 pts

This criterion is linked to a Learning Outcome
Explain how the results would be used to make a diagnosis. 92 y/o African American male is brought to the Emergency Department by his daughter. The patient has slurred speech. His blood pressure is 210/100

15
 
to >
12.0
 pts
Excellent
The response clearly, accurately, and in detail explains how the results would be used to make a diagnosis.

12
 
to >
9.0
 pts
Good
The response accurately explains how the results would be used to make a diagnosis.

9
 
to >
6.0
 pts
Fair
The response vaguely and with some inaccuracy explains how the results would be used to make a diagnosis.

6
 
to >
0
 pts
Poor
The response explains inaccurately and/or is missing how the results would be used to make a diagnosis.

15
 pts

This criterion is linked to a Learning Outcome
Identify three to five (3–5) possible conditions that may be considered in a differential diagnosis for the patient. Explain your thinking.

35
 
to >
29.0
 pts
Excellent
The response clearly, accurately, and in detail identifies four or five possible conditions that may be considered in a differential diagnosis for the patient; with clear, accurate, and detailed reasoning for each possible condition.

29
 
to >
23.0
 pts
Good
The response accurately identifies three to five possible conditions that may be considered in a differential diagnosis for the patient; with accurate reasoning for each possible condition.

23
 
to >
17.0
 pts
Fair
The response vaguely and lacking specificity identifies three possible conditions that may be considered in a differential diagnosis for the patient; with vague reasoning for each possible condition.

17
 
to >
0
 pts
Poor
The response inadequately identifies fewer than three possible conditions that may be considered in a differential diagnosis for the patient; with inadequate or missing reasoning for each possible condition.

35
 pts

This criterion is linked to a Learning Outcome
Written Expression and Formatting: Paragraph Development and Organization — Paragraphs make clear points that support well-developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused and neither long and rambling nor short and lacking substance. A clear and comprehensive purpose statement and introduction are provided that delineate all required criteria.

5
 
to >
4.0
 pts
Excellent
Paragraphs and sentences follow writing standards for flow, continuity, and clarity. A clear and comprehensive purpose statement, introduction, and conclusion are provided that delineate all required criteria.

4
 
to >
3.0
 pts
Good
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time. Purpose, introduction, and conclusion of the assignment are stated, yet are brief and not descriptive.

3
 
to >
2.0
 pts
Fair
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time. Purpose, introduction, and conclusion of the assignment are vague or off topic 92 y/o African American male is brought to the Emergency Department by his daughter. The patient has slurred speech. His blood pressure is 210/100.

2
 
to >
0
 pts
Poor
Paragraphs and sentences follow writing standards for flow, continuity, and clarity < 60% of the time. No purpose statement, introduction, or conclusion were provided. 5  pts This criterion is linked to a Learning Outcome Written Expression and Formatting: English Writing Standards — Correct grammar, mechanics, and proper punctuation 5   to >
4.0
 pts
Excellent
Uses correct grammar, spelling, and punctuation with no errors.

4
 
to >
3.0
 pts
Good
Contains a few (1 or 2) grammar, spelling, and punctuation errors.

3
 
to >
2.0
 pts
Fair
Contains several (3 or 4) grammar, spelling, and punctuation errors.

2
 
to >
0
 pts
Poor
Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding.

5
 pts

This criterion is linked to a Learning Outcome
Written Expression and Formatting: APA The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, running heads, parenthetical/in-text citations, and reference list. 92 y/o African American male is brought to the Emergency Department by his daughter. The patient has slurred speech. His blood pressure is 210/100

5
 
to >
4.0
 pts
Excellent
Uses correct APA format with no errors.

4
 
to >
3.0
 pts
Good
Contains a few (1 or 2) APA format errors.

3
 
to >
2.0
 pts
Fair
Contains several (3 or 4) APA format errors.

2
 
to >
0
 pts
Poor
Contains many (≥ 5) APA format errors.

92 y/o African American male is brought to the Emergency Department by his daughter. The patient has slurred speech. His blood pressure is 210/100

5
 pts

Total Points: 
100

Florida and New Jersey APRN license requirements

An Analysis and Comparison of APRN Board of Nursing Regulations in New Jersey and Florida

APRNs provide safe, efficient, and effective care alongside or better than physicians. State laws and regulations that restrict practice, however, pose significant obstacles to offering the entire area of practice. In regions where there is a medical need and for populations with fewer doctors and financial resources, the full spectrum of practice is essential. The demand for affordable solutions and the quickly evolving healthcare system are issues that APRNs may assist with. Florida and New Jersey have a lot in common, so they can cooperate to solve APRNs’ problems.

Scope of Practice Regulations

Advanced Practice Registered Nurses (APRNs) are subject to different professional performance requirements under the two Florida statutes and regulations. According to Florida Statute 464, an advanced practice nurse is a licensed nurse who satisfies requirements and is qualified to carry out advanced nursing practices (n.d.). Regulations in either state do not restrict APRN collaboration or referral. Within the boundaries of a certified nurse anesthetist practice, nurse anesthetists are qualified to provide anesthesia services.

New Jersey Regulations

The State Board of Nursing in New Jersey grants advanced practice nursing credentials and manages the necessary registry requirements, education requirements, and disciplinary actions. Nurses need to be nationally certified and have a current license. To prescribe, dispense, or administer medication, they must finish continuing education requirements and collaborate with other physicians. Physician participation and written guidelines are necessary for long-term care facilities. In New Jersey, the national board certification governs all advanced practice.

PLACE YOUR ORDER HERE

Florida Regulations

Florida permits licensure for APRN positions that require recognized qualifications, such as CNM, NP, and CNS (n.d.). Following Board of Nursing clearance, ARNPs are eligible to apply for a prescribing authority certificate and a dispensing authority certificate. Rules outline clinic practice regulations, patient care instructions, and irresponsible prescriptions, along with providing appropriate supervision. ARNPs who provide a transcript form are exempt from application and registration fees. The Board of Nursing establishes practice guidelines and confers on other boards to propose laws. The measure gives the Board of Nursing and other boards the authority to establish guidelines, revise procedures, and assess program objectives on an annual basis.

                                                                Prescriptive Authority Regulations

New Jersey Regulations

A master’s degree in advanced practice nursing from an authorized program is required by the New Jersey Board of Nursing. The program’s objectives include preparing practitioners for nursing care, health maintenance, healthcare counseling, and assessment. Candidates need to hold a certification from an established professional association. Advanced practice nurses can prescribe medication, healthcare services, therapeutic interventions, and diagnostic guidelines. They can work in tandem with certified medical professionals, such as doctors or midwives, and assign nursing tasks according to their professional opinion. APRNs must report any collaborations to the Board of Nursing within a 14-day period. As of recent updates, regulations emphasize the importance of maintaining a collaborative practice environment (New Jersey Board of Nursing, 2021).

Florida Regulations

There are four different titles for advanced practice nurses (APRNs) in Florida: Advanced Registered Nurse Practitioner, Clinical Nurse Specialist, Certified Registered Nurse Anesthetist, and Certified Nurse Midwife. The Florida Department of Health requires them to be licensed registered nurses (RNs), pass the national certification exam, complete a graduate-level pharmacology course, and maintain 30 continuing education units every two years. A formal practice protocol with a Florida-licensed physician or clinical nurse specialist is mandatory for ARNPs. The Florida Department of Health Board of Nursing has created general statutes and regulations that apply to all ARNPs in Florida. The state has made strides towards full practice authority for APRNs, allowing them to function with greater autonomy (Florida Board of Nursing, 2022).

Application of Regulations to APRNs

Advanced practice nurses are subject to New Jersey and Florida regulations, with New Jersey requiring education programs and practice standards. While Florida regulations outline the scope of practice for advanced registered nurse practitioners, they limit formulary and prescribing privileges. Physicians can only supervise one advanced registered nurse practitioner unless approved by the board.

New Jersey Examples of Compliance

In New Jersey, the New Jersey Board of Nursing oversees compliance with the Nurse Practice Act. This includes licensing, education, and standards of conduct. As an example of recent compliance, consider the following: Mandatory Continuing Education: Nurses are required to complete continuing education units (CEUs) to maintain their licenses, ensuring that they remain current with best practices and new regulations (New Jersey Division of Consumer Affairs, 2021).

Telehealth Regulations: The board has amended regulations to include telehealth practices, ensuring that nurses adhere to standards while providing remote care (New Jersey Division of Consumer Affairs, 2021).

Florida Examples of Compliance

 
The Florida Board of Nursing also enforces regulations like New Jersey’s, with specific emphasis on patient safety and ethical practice. Compliance examples include:

Florida mandates that all licensed nurses complete a certain number of CEUs for license renewal, similar to New Jersey. This ensures ongoing professional development (Florida Board of Nursing, 2022).

Actions: Florida has a structured disciplinary framework for non-compliance, including fines and license suspension for violations such as practicing without a valid license (Florida Board of Nursing, 2022)

 
Conclusion

 
All nurse practitioners (NP) and clinical nurse specialists (CNS) are required to practice as advanced practice nurses (APNs) in accordance with the rules of the New Jersey and Florida Boards of Nursing. After discussing the role of the APN, the suggested Consensus Model is analyzed. This will result in unified legislation as well as increased understanding among the public, the nursing profession, and other healthcare practitioners. We strongly advocate for the states to adopt uniform regulations, and we offer our suggestions for improving the proposed Consensus Model. Some of these suggestions include renaming the four roles under the APN and retaining the stricter requirements of national certification, education competency, and professional colleague collaboration. To ensure a safe practice and address the lack of public understanding about the role of an APN, the NJ regulations remain silent on this matter. The geographical boundaries of New Jersey restrict the scope of practice; this limitation leads to misunderstandings and restrictions regarding the range of services and care that an APN from NJ can offer in other states. NJBON regulates the practice requirements, recognition, and qualifications for several nursing titles, including APNs, RNs, and nurses, to qualify for and retain these four responsibilities.

References

Florida Board of Nursing. (2022). Advanced practice registered nursing. Retrieved from https://floridasnursing.gov/

Florida Board of Nursing. (2022). Nursing regulations and practices. Retrieved from 

Homepage

Links to an external site.

Florida Legislature. (n.d.). Chapter 464: Nursing. Retrieved from 
https://www.flsenate.gov/Laws/Statutes/2023/464
Links to an external site.

New Jersey Board of Nursing. (2021). Advanced practice nurse prescriptive authority. Retrieved from 
https://www.nj.gov/state/
Links to an external site.

New Jersey Division of Consumer Affairs. (2021). New Jersey Board of Nursing: Laws and regulations. Retrieved from 
https://www.nj.gov/oag/ca/consumer.htm
Links to an external site.

Comparison of APRN Regulations in West Texas and North Central New Mexico

Regulation 1: Scope of Practice

West Texas: In Texas, APRNs must practice under a physician’s autonomy by requiring physician oversight for diagnosing, treating, and prescribing, particularly for controlled substances; for example, an APRN in West Texas needs a signed protocol with a collaborating physician detailing specific treatments and medications they can prescribe. The Texas Board of Nursing does not have a list of tasks that every APRN can or cannot perform (Texas Board of Nursing. 2022). The physician must regularly review a certain percentage of patient records, impeding timely care decisions.

North Central New Mexico: APRN Certified Nurse Practitioners (CNP) in New Mexico enjoy full practice authority, meaning they can independently evaluate, diagnose, interpret diagnostic tests, and initiate treatment plans without physician collaboration or oversight. For example, an APRN in North Central New Mexico can operate independently, managing patient care and making decisions in real-time. This is especially beneficial in rural settings where physician access might be limited.

Regulation 2: Prescriptive Authority

West Texas: Texas regulations require APRNs to have a prescriptive authority agreement with a physician to prescribe medications, including controlled substances. This agreement mandated a specific number of face-to-face meetings between the APRN and the physician and required documented discussions about care decisions. For instance, an APRN in West Texas prescribing a controlled medication must adhere to the stipulations of their prescription with their collaborating physician, delaying the initiation of necessary medicines.

PLACE YOUR ORDER HERE

North Central New Mexico: In New Mexico, APRNs have independent prescriptive authority, including for controlled substances, if they have completed the required pharmacology education and meet state licensure standards. The only drugs to be included in the formulary are those relevant to the CNP’s specialty and practice setting (New Mexico Board of Nursing. 2022).  This independence allows APRNs to respond immediately to patients’ needs without consulting a supervising physician, streamlining care processes and improving patient outcomes. For instance, an APRN can adjust a patient’s medication for chronic pain management without having to schedule a consultation with a physician.

Application of Regulations to APRNs’ Practice

Texas: The collaborative and prescriptive authority agreements in Texas restrict APRNs’ ability to exercise their education and expertise fully, often requiring time-consuming meetings and physician approvals. This dependency can limit an APRN’s capacity to provide timely and comprehensive care, particularly in regions where physician availability is inconsistent. It is the position of the American Academy of Nursing (Academy) that the FPA of APRNs is essential to achieving health equity (Bosse, J, 2017). For example, an APRN with extensive experience managing chronic conditions may find their clinical decision-making delayed or altered due to the need for physician sign-off on treatment changes.

New Mexico: The full practice authority in New Mexico empowers APRNs to utilize their skills and training completely, allowing them to manage patient care from diagnosis to treatment independently. This regulatory environment maximizes APRN efficiency, particularly in underserved areas where APRNs can fill critical gaps in care. For example, an APRN running a rural health clinic in North Central, New Mexico, can independently prescribe medications and adjust treatment plans without external approvals, providing patients with immediate and continuous care.

Examples of APRNs Adhering to Selected Regulations

West Texas Examples: An APRN working in a rural clinic in West Texas adheres to state regulations by maintaining a detailed collaborative agreement with a supervising physician. This agreement outlines specific treatments and medications the APRN can manage independently and those that require physician oversight. The APRN regularly meets with the physician to discuss complex cases and prescriptive decisions, documenting these interactions as required by Texas laws Comparison of APRN Regulations in West Texas and North Central New Mexico.

North Central New Mexico Example: An APRN in North Central New Mexico operates a primary care practice independently assessing, diagnosing, and treating patients. They adhere to state regulations by ensuring all prescriptive actions are within their licensure scope and training. For example, the APRN may adjust a diabetic patient’s insulin dosage based on clinical assessment during a visit without consulting or informing a supervising physician, adhering to New Mexico’s independent practice regulations.

Conclusion

This comparison highlights state regulations’ significant impact on APRNs’ autonomy and ability to practice to the full extent of their education. While Texas APRNs faces more restrictive practices requiring physician collaboration, New Mexico APRNs benefit from full practice authority, allowing them to provide comprehensive, independent care, especially crucial in rural and underserved areas. Understanding these regulatory differences is essential for APRNs to navigate their practice environments effectively and advocate for changes that promote greater autonomy in their professional roles.

 

References:

Texas Board of Nursing. (2022). 
Advanced practice registered nurses: Rules and regulations. 
Texas Board of Nursing. Retrieved from 
https://www.bon.texas.gov
Links to an external site.

New Mexico Board of Nursing. (2022). 
Licensure and practice requirements for APRNs. 
New Mexico Board of Nursing. Retrieved from 
https://nmbon.sks.com
Links to an external site.

Bosse, J., Simmonds, K., Hanson, C., Pulcini, J., Dunphy, L., VanHook, P., & Poghosyan, L. (2017). Position statement: Full Practice authority for advanced practice register

Colorado and Montana aprn licensure comparison

Main Discussion Post Week 5

In comparing Advanced Practice Registered Nurse (APRN) Board of Nursing regulations between Colorado and Montana, key distinctions highlight differences in scope of practice, licensing, and supervision requirements (American Nurses Association, n.d.). The regulatory framework for APRNs includes seven main elements: title, license, four roles (Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist, and Clinical Nurse Specialist), education, national certification, independent practice, and independent prescribing (National Council of State Boards of Nursing (NCSBN), n.d.).

One regulation that stands out is the Independent Practice Authority. In Colorado, an APRN looking to adhere to independent practice authority must complete a 1,000-hour mentorship period under a physician’s or experienced APRN’s supervision before they can practice independently (Maryville University, n.d.). For example, a family nurse practitioner (FNP) who has recently graduated and obtained their APRN license must collaborate with a supervising healthcare provider during this mentorship phase. After completing these required hours, they can legally open their own practice and fully exercise their scope of practice without further supervision. In Montana, an APRN enjoys full practice authority upon licensure without any mandatory supervisory period (Maryville University, n.d.). For instance, an APRN moving to Montana from another state could immediately begin an independent practice and prescribe medications, including controlled substances, right after obtaining licensure. An example could be a psychiatric nurse practitioner (PMHNP) who can establish their own mental health practice and immediately begin providing care without the need for supervision. This system allows APRNs to fully utilize their training and skills as soon as they are licensed.

GET A CUSTOM-WRITTEN PAPER NOW

A second regulation that stands out is the prescriptive authority. If APRNs in Colorado want to prescribe medications, they must first complete a 1,000-hour supervised practice period before gaining prescriptive authority for controlled substances, including opioids. This supervised period is a safeguard to ensure new APRNs are adequately prepared for independent practice, but it may delay full autonomy for some practitioners. Montana allows APRNs full prescriptive authority, including controlled and non-controlled substances, but with fewer restrictions. APRNs in Montana do not need to complete a mentorship or supervised practice period before gaining this authority, which provides them immediate access to prescribing rights upon licensure without a mandatory supervisory period. Following the example above, a PMHNP can immediately begin prescribing psychotropic medications without the need for supervision Colorado and Montana aprn licensure comparison.

Supervised hours should be required for all states, especially for nurses who achieved their APRN without working as a bedside RN. However, reviewing the article by Neff et al. (2018) confirms that allowing APRNs to practice immediately would have a profound effect in rural areas by decreasing drive time for patients and increasing access to care. Unfortunately, I believe bedside care is essential for any APRN’s future as an independent provider and prescriber. Providing background on bedside caregivers’ years of experience should be considered. Depending on years of experience and area of practice, an APRN should be granted full independent practice and prescriptive authority.

The key differences lie in Colorado’s requirement for a supervised practice or mentorship period for independent and prescriptive authority, whereas Montana grants these privileges to APRNs immediately upon licensure. This difference impacts how quickly APRNs in each state can exercise their full range of skills and knowledge in their professional roles. These variations reflect each state’s approach to balancing APRN autonomy with patient safety, allowing nurses in both Colorado and Montana to work within the regulations to provide comprehensive care.

References

American Nurses Association. (n.d.). 
ANA enterprise.
 http://www.nursingworld.org

Maryville University. (n.d.). 
States with full practice authority for Nurse Practitioners.
 
https://nursing.maryville.edu/blog/states-granting-np-full-practice-authority.html#:~:text=NPs%20who%20work%20in%20Colorado,a%20physician%20or%20mentoring%20NP
Links to an external site.

National Council of State Boards of Nursing (NCSBN). (n.d.). 
APRN Consensus Model.
 
https://www.ncsbn.org/nursing-regulation/practice/aprn.page
Links to an external site.

Neff, D. F., Yoon, S. H., Steiner, R. L., Bumbach, M. D., Everhart, D., & Harman J. S. (2018). The impact of nurse practitioner regulations on population access to care. 
Nursing Outlook, 66
(4), 379–385 Colorado and Montana aprn licensure comparison

NURS-6050

Week 4: Assignment –
Legislation Grid and Testimony/Advocacy Statement – Safe Staffing for nurse and Patient Safety Act of 2023 Advocacy Essay Assignment

To Prepare:

Select a bill that has been proposed (not one that has been enacted) using the congressional websites provided in the Learning Resources.

The Assignment: (1- to 2-page Legislation Grid; 1-page Legislation Testimony/Advocacy Statement)

Be sure to add a title page, an introduction, purpose statement, and a conclusion. This is an APA paper.

Part 1: Legislation Grid

Based on the health-related bill (proposed, not enacted) you selected, complete the Legislation Grid Template. Be sure to address the following:

Determine the legislative intent of the bill you have reviewed.

Identify the proponents/opponents of the bill.

Identify the target populations addressed by the bill.

Where in the process is the bill currently? Is it in hearings or committees?

Part 2: Legislation Testimony/Advocacy Statement

Based on the health-related bill you selected, develop a 1-page Legislation Testimony/Advocacy Statement that addresses the following:

Advocate a position for the bill you selected and write testimony in support of your position.

Explain how the social determinants of income, age, education, or gender affect this legislation.

Describe how you would address the opponent to your position. Be specific and provide examples.

At least 2 outside resources and 2-3 course specific resources are used.

Advocacy for the Safe Staffing for Nurse and Patient Safety Act of 2023

Part I

Legislation Grid Template

Use this document to complete Part 1 of the Module 2 Assessment
Legislation Grid and Testimony/Advocacy Statement

Health-related Bill Name

 

Safe Staffing for Nurse and Patient Safety Act of 2023 (AHRQ, 2024)

Bill Number

H.R. 2581

Description

This bill requires every healthcare facility to adopt safe nurse-to-patient staffing ratios. The bill would prevent nurses from caring for more patients than they are capable of safely handling at any given time, thus decreasing errors and the quality of care provided (American Nurses Association, 2023). It will also create good working conditions for the nurses themselves in order to prevent burnout and turnover.

Federal or State?

Federal

Legislative Intent

This bill will promote patient safety and quality care by requiring hospitals and other healthcare facilities to meet minimum standards of nurse staffing so that each nurse will be able to manage their workload in the delivery of the highest form of patient care.

Proponents/ Opponents

Proponents:
Congresswoman Jan Schakowsky; Senator Sherrod Brown.

Opponents:
Hospital administrators, some healthcare organizations citing increased costs, and concerns about operational flexibility.

Target Population

Hospital patients, particularly those in acute care settings, and nurses working in healthcare facilities.

PLACE YOUR ORDER HERE

Status of the bill (Is it in hearings or committees?)

The bill is currently in committee, where it is being reviewed and considered before moving to a potential floor vote.
NURS-6050

Week 4: Assignment –
Legislation Grid and Testimony/Advocacy Statement – Safe Staffing for nurse and Patient Safety Act of 2023 Advocacy Essay Assignment

General Notes/Comments

 

 

This bill responds to ongoing issues of nurse burnout and patient safety concerns related to staffing levels. Supporters argue that safe staffing ratios are necessary to protect both nurses and patients, while opponents worry about the financial impact on healthcare systems.

 

PART II

Advocacy for the Safe Staffing for Nurse and Patient Safety Act of 2023

The Safe Staffing for Nurses and
Patient Safety Act of 2023
is landmark legislation that solves the growing crisis in health staffing and protects both patient outcomes and well-being. This bill will require ratios of nurse-to-patient staffing for safety that will help reduce burnout, minimize medical errors, and ultimately improve patient care. Nurses are at the very center of healthcare delivery, and it is no secret that an increasing number are overwhelmed by dangerous staffing shortages in hospitals across the nation (Tamata & Mohammadnezhad, 2022). These conditions not only put the patients in danger but also put the nurses under immense pressure that could threaten their mental and physical health.

Income, age, education, and gender make up the societal determinants that mix directly to determine the impact of this proposed legislation. Communities with lower incomes normally have hospitals that are understaffed to a crippling degree, diminishing patient care. Older patients, by nature requiring more care, become highly vulnerable in understaffed facilities.

Also, nursing is a female-dominated profession, and inequities in pay and working conditions because of gender are ongoing; hence, this staffing ensures that social justice around safe care is observed (Mwetulundila & Indongo, 2022). The bill ensures that underserved populations receive equal access to quality health care and supports nurses in caring for their patients’ needs.

Opponents of the bill argue that staffing mandates would be financially burdensome for hospitals, especially smaller and rural ones. However, this argument is far outweighed by evidence of the fact that appropriate staffing reduces costly complications and hospital readmissions, saving money in the long run (McHugh et al., 2021). Hospitals that invest in safe staffing see improved nurse retention, reducing recruitment and training costs. For example, a study in California indicated that hospitals with safe staffing ratios realized savings through costs associated with temporary staffing and turnover of nurses (Dierkes et al., 2021). Safe staffing is not only economically viable but also intrinsic to constructing a sustainable and quality healthcare system.

References

Dierkes, A., Do, D., Morin, H., Rochman, M., Sloane, D., & McHugh, M. (2021). The impact of California’s staffing mandate and the economic recession on registered nurse staffing levels: A longitudinal analysis.
Nursing Outlook
,
70
(2). https://doi.org/10.1016/j.outlook.2021.09.007

McHugh, M., Aiken, L., Sloane, D., Windsor, C., Douglas, C., & Yates, P. (2021). Effects of nurse-to-patient ratio legislation on nurse staffing and patient mortality, readmissions, and length of stay: a prospective study in a panel of hospitals.
The Lancet
,
397
(10288), 1905–1913. https://doi.org/10.1016/S0140-6736(21)00768-6

Mwetulundila, P., & Indongo, N. (2022). Gender Equity and Impedes of Career Progression in the Nursing Profession in Khomas Region of Namibia.
SAGE Open Nursing
,
8
, 237796082210746. https://doi.org/10.1177/23779608221074652

Tamata, A. T., & Mohammadnezhad, M. (2022). A Systematic Review Study on the Factors Affecting Shortage of Nursing Workforce in the Hospitals.
Nursing Open
,
10
(3), 1247–1257. https://doi.org/10.1002/nop2.1434
NURS-6050

Week 4: Assignment –
Legislation Grid and Testimony/Advocacy Statement – Safe Staffing for nurse and Patient Safety Act of 2023 Advocacy Essay Assignment